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Abstract 
 
Asf1 is a histone chaperone, which participates in the assembly and disassembly of 
histones H3/H4 on DNA. Asf1 is not essential for cell viability in yeast, but the DNA 
damage checkpoints are constitutively activated in cells lacking Asf1 and they are 
hypersensitive to several types of genotoxic stress. In yeast, Asf1 forms a stable 
complex with Rad53 in the absence of genotoxic stress. Our results suggest that this 
complex involves at Ieast three interaction surfaces. One site involves the H3-binding 
surface of Asf1 with an as yet undefined surface of Rad53, probably reside in the 
kinase domain of Rad53. A second site is formed by the Rad53-FHA1 domain binding 
to Asf1-T270. The third site involves the C-terminal 21 aa of Rad53 bound to the 
conserved Asf1 N-terminal domain, where Rad53 competes with histone H3/H4 and 
co-chaperones HirA/CAF-1 for binding to the same surface of Asf1. Rad53 is 
phosphorylated and activated upon genotoxic stress. The Asf1-Rad53 complex 
dissociated when cells were treated with hydroxyurea but not methyl methane 
sulfonate, suggesting a regulation of the complex as a function of the stress. 
In addition to these results, we also found that the rad53-A806R+L808R mutation at 
the C-terminus of Rad53 destabilized the Asf1-Rad53 interaction and increased the 
viability of rad9 and rad24 mutants to genotoxic stress. The rad53-ALRR mutant also 
appeared to re-enter the cell cycle and/or traverse S-phase more rapidly than wild 
type and increased repair or adaptation when combined with the rad24 mutant.  
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Abbreviations 
 
4-NQO : 4nitroquinoline 1-oxide 
9-1-1 : Rad9-Rad1-Hus1 
ARS : Autonomous replicating sequence 
Asf1 : Anti-silencing factor-1 
ATM : Ataxia telangiectasia mutated 
ATR : Ataxia telangiectasia and Rad3 related 
BrdU : Bromodeoxyuridine 
bp :  base pair 
CAF-1 : chromatin assembly factor-1 
CDK : Cyclin-dependent kinase 
CIP : Calf intestinal phophatase 
CK2 : Casein kinase 2 
CPT : Camptothecin 
CDK : cyclin-dependent kinase 
DDK : Dbf4-dependent kinases 
DDR : DNA damage response 
DNA : deoxyribonucleic acid 
dNTP: deoxyribonukleotide 
DSB : double strand break 
DTT : dithiothreitol 
Csm3 : chromosome segregation in meiosis 
FACS : Fluorescence activated cell sorting 
FHA : forkhead-associated domain 
GCR : gross chromosomal rearrangement 
GST : Glutathione-S-transferase 
HIR : Histone regulation 
HA : Hemagglutinin 
HR : Homologous recombination 
HU : hydroxyurea 
IP: Immunoprecipitation 
IPTG: Isopropyl-β-D-thiogalaktopyranosid 
kd : kinase dead 
MCM : minichromosome maintenance 
Mec1 : Mitosis entry checkpoint mutant 1  
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MMS : Methylmethanesulfonate 
MRN : Mre11, Rad50, Nbs1 
MRX : Mre11, Rad50,Xrs2 
NHEJ : Non-homologous end joining 
NLS : Nuclear localization signal/sequence 
PCNA : proliferating cell nuclear antigen  
PCR : Polymerase chain reaction 
PI3K : Phosphoinositide-3 kinase 
Pol : Polymerase 
Rad53 : Radiation sensitive mutant 53 
RNR : ribonucleotide reductase 
RPA : replication protein A 
S.cerevisiae : Saccharomyces cerevisiae 
SCD : SQ/TQ cluster domain 
SDS-PAGE : Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
S.pombe : Schizosaccharomyces pombe 
ssDNA : single-strand DNA 
TAP : Tandem Affinity Purification 
Tel1 : Telomere maintenance mutant 1 
Tof1 : Topoisomerase I interacting factor 
WT : Wildtype 
YFP : Yellow fluorescent protein 
YPD: Yeast extract peptone dextrose 
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Introduction 
 
 
 
Model: Saccharomyces cerevisiae 
 
The budding yeast Saccharomyces cerevisiae is a useful model for studying higher 
eukaryotic organisms. S.cerevisiae has many technical advantages such as rapid growth, 
dispersed cells, mutant isolation, a well-defined genetic system, numerous selective 
markers and easy gene manipulation. The genome of S.cerevisiae was completely 
sequenced in 1996 (Goffeau et al, 1996). It is composed of about 13,000,000 bp and 6,275 
genes. It is estimated that 23% of yeast genes have homologs in the human genome, and 
30% of known genes involved in human diseases have yeast orthologs. Additionally, the 
conservation of many cellular processes in eukaryotes, such as DNA replication, DNA 
damage checkpoints and cell cycle control also establishes the usefulness of yeast in the 
study of human disease (Johnson and O’Donnell, 2005; Lee and Nurse, 1987; Perego et al, 
2000; Zhou and Elledge, 2000).   
 
 
1.1 Genome stability 
 
The maintenance of genomic stability is beneficial for the survival of an individual cell and 
crucial for cancer avoidance. Cells invest huge resources to maintain genomic stability, and 
cancer cells undergo an array of genetic changes to escape these barriers. 
Defects in chromatin modulation and choromosomal aberrations, including altered 
chromatin structure in repetitive DNA, chromosome rearrangements and chromosome loss, 
are reflective of genomic instability and are a hallmark of cancer cells (Myung et al, 2003; 
Prado et al, 2004; Melo et al, 2007; Kops et al, 2005; Mitelman et al, 2007). 
In addition, the DNA checkpoint pathway was originally identified in S.cerevisiae, because 
their loss of fuction resulted in defects in cell cycle progression in response to DNA damge. 
The absence of checkpoints can be lethal to cells. In cells mutated for checkpoint 
components, the spontaneous and induced chromosomal rearrangements are significantly 
increased (Hartwell et al, 1994; Myung et al. 2001; Kolodner et al. 2002; Myung and 
Kolodner, 2002). These results demonstrate that checkpoint proteins also play important 
roles in maintaining genomic stability. 
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1.2 Chromatin 
 
1.2.1 Nucleosome and chromatin structure 
 
In eukaryotic cells, genomic DNA is packaged in chromatin as nucleosomes. The basic unit 
of chromatin is the nuclesome, consisting of 147bp of DNA wrapped around a histone 
octamer containing two copies each of histones H2A, H2B, H3 and H4 (Figure 1). The 
histone proteins are highly conserved across all eukaryotes. Histone proteins contain two 
functional domains: a core histone-fold domain involved in histone/histone and histone/DNA 
interactions, and a flexible N-terminal tail domain where a variety of covalent post-
translational modifications sites have been studied (Luger et al, 1997). However, little is 
known about the conformation of the histone tails. 
Two nuclesome core particles are separated by linker DNA varying in length from 10 to 80 
bp. Histone H1 locks the linker DNA at the entry and exit points of the nucleosome. H1 
participates in nucleosome positioning or spacing and formation of the higher-order 
chromatin structure (Ramakrishnan, 1997; Widom, 1998; Thomas, 1999; Maier et al. 2008). 
The primary chromatin structure consisting of nucleosomes assembled along DNA 
resembles ‘beads on a string’ as seen by electron microscopy (Woodcock et al, 2006). This 
chromatin fiber may then be further folded and compacted into higher-order chromatin 
structure that allows the packaging of the genomic DNA into the nucleus  (Horn et al, 2002). 
The light-microscopy studies have revealed at least two types of chromatin: 
heterochromatin that stays condensed after cell division and euchromatin that decondenses 
during interphase (Grewal et al. 2002; Elgin et al. 2003; Maison et al. 2004). Euchromatin 
can either be actively transcribed or repressed whereas heterochromatin is commonly 
defined as transcriptionally repressed appearing in large units at the centromeres and 
telomeres (Grewal et al. 2007). 
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Figure 1. The structure of a nucleosome core particle defined by X-ray crystallography at 
2.8 Å resolution. The core particle contains of two copies of H2A, H2B, H3 and H4 and 
DNA. The view is from the top through the superhelical axis (Lunger et al, 1997). The 
histone globular domain consists of three α helices connected by two flexible loops and is 
referred to as the histone fold domain which allows histones to dimerize head to tail in a 
handshake manner (Arents and Moudrianakis, 1995). 
 
1.2.2 Chromatin dynamics 
  
Chromatin structure and packaging of the genome is important for regulating the cellular 
processes such as transcription, replication and repair (Kornberg et al, 1999). Therefore, 
factors that can alter chromatin structure are essential for and provide additional regulatory 
points in these cellular processes. The chromatin structure is highly dynamic to enable 
rapid unfolding, disassembly and refolding. Three main mechanisms that control the 
dynamics of chromatin structure have been identified: histone post-translational 
modification (PTMs), histone variants and ATP-dependent chromatin remodeling factors 
(remodelers). 
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1.2.2.1 Histone modifications  
 
PTMs constitute reversible covalent modifications of amino acidic residues, such as serine 
and threonine phosphorylation, lysine acetylation, lysine and arginine methylation and 
lysine ubiquitination, among others. These PTMs modulate chromatin structure and/or 
recruit proteins to chromatin to mediate distinct cellular processes, including gene 
transcription, DNA replication and DNA repair (Strahl and Allis, 2000; Turner, 2000; 
Jenuwein and Allis, 2001; Vidanes et al., 2005). Each of these modifications is catalyzed by 
a specific family of enzymes. For example, histone acetyltransferases, methyltransferases, 
kinases and ubiquitin ligases, as well as the enzymes that remove these modifications.  
The majority of histone PTMs were found in the N-terminal tails of histones that extend out 
from the globular core of the nucleosome, creating chromatin structures favourable either 
for activation or repression of genes through altering the degree of chromatin compaction 
(Luger et al, 1998). However, recent work has shown that modifications in the globular core 
play crucial roles in regulating the structure and function of chromatin and controlling 
biological function, such as H3K56 and H4K91 acetylation (Cosgrove et al, 2004; 
Masumoto et al, 2005; Xu et al, 2005; Hyland et al, 2005; Ye et al, 2005).  
Some histone PTMs are induced in response to DNA damage (Figure 2). These histone 
PTMs may increase the plasticity of chromatin and facilitate the access of DNA repair and 
checkpoint proteins to sites of DNA lesions. After repair of lesions, PTMs are cleared for 
restoration of the chromatin structure and the shut down of checkpoint signaling. Several 
typical conserved PTMs are introduced here. 
In mammals, phosphorylation of serine-139 in the C-terminal SQE motif of histone H2AX is 
rapidly induced at DSBs, and was named γ-H2AX (Rogakou et al, 1998). In yeast, this 
phosphorylation (γ-H2A) occurs at serine 129 in the most abundant form of histone H2A 
(Downs et al, 2000). This phosphorylation is catalysed by DNA damage checkpoint protein 
kinases: ATM, ATR and DNA-PK kinases in human cells (Burma et al, 2001; Ward et al, 
2001; Stiff et al, 2004) or their homologues Mec1 and Tel1 in budding yeast (Downs et al, 
2000; Redon et al, 2003; Nakamura et al, 2004) These kinases are recruited to DSBs 
through their association with partner proteins that recognise DNA lesions either directly or 
indirectly (Zou et al, 2003; Falck et al, 2005). The formation of γH2AX nuclear foci has been 
proven to be a DSB marker in mammalian cells. Although γH2AX is not essential for the 
initial recruitment of DSB response factors, it stabilizes the binding of the checkpoint factors, 
and it is required for effective repair of DSBs by both the NHEJ and HR pathways 
(Karagiannis et al, 2007; Celeste et al, 2002; 2003). Dephosphorylation of γH2AX by HTP-
C (Histone phosphatase H2A complex) is necessary for the efficient recovery from DNA 
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damage after DNA repair. γH2AX recruits ubiquitin ligases that participate in the further 
recruitment of downstream players in the DNA damage response (Huen et al, 2007; 
Mailand et al, 2007; Kolas et al, 2007). 
In yeast, H3K56 acetylation by Rtt109 is important for DNA damage response signaling and 
histone reassembly after DNA repair (Schneider et al, 2006). These acetylations regulate 
the binding of H3-H4 with histone chaperone CAF-1, but not Rtt106, to promote 
nucleosome assembly (Burgess et al, 2010). H3K56-Ac has been shown to require the 
histone chaperone Asf1 and occurs at the S phase in unstressed cells. Its role will be 
discussed in chapter 3.2.2.  
The methyltransferase Dot1 mediates H3K79 methylation in both yeast and mammalian 
cells. In budding yeast, increased accessibility of H3K79me3 at DSBs is implicated in the 
recruitment of the Rad9 checkpoint adaptor protein (Bonilla et al, 2008; Huyen et al, 2004; 
Wysocki et al, 2005). 
The recent studies have revealed that histone acetylation is important for promoting 
nucleosome assembly by enhancing histone binding with distinct histone chaperones. For 
example, the most highly-conserved mark of newly-synthesized histones is H4-K5, 8, 12, 
16 acetylation which is conserved from yeast to humans. They are generally acetylated by 
a number of HATs such as NuA4, Gcn5 and in yeast. These acetylations may facilitate 
histone assembly into nucleosomes and facilitate DNA repair by non-homologous end 
joining (NHEJ) and homologous recombination (HR) (Sobel et al, 1995; Parthun et al, 1996; 
Bird et al, 2002; Murr et al, 2006; Murr et al, 2007). Following deposition onto the DNA, the 
newly synthesized H4 is rapidly deacetylated, which is required for proper chromatin 
maturation (Sobel et al, 1995; Loyola et al, 2006). H4-K16Ac inhibits the formation of 
compact 30-nanometer–like fibres and impedes the ability of chromatin to form cross-fibre 
interactions (Shogren-Knaak et al, 2006). In addition, methylation of histone H4-K20 is 
essential for recruiting the orthologous checkpoint proteins 53BP1 (mammals) and Crb2 
(fission yeast) to sites of DSBs and subsequent activation of a DNA damage checkpoint.  
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Figure 2. Some histone PTMs are induced in response to DNA damage in yeast, such as 
γH2A/H2A.X, H3K56 Ac, H3K79 me3 and H4K5, 8, 12,16 Ac, which may increase the 
plasticity of chromatin, facilitate the access of DNA repair and checkpoint proteins to sites 
of DNA lesions.  
 
1.2.2.2    Histone variants 
 
Histone variants are distinct, non-allelic isoforms of the major histone types (Redon et al, 
2002). The incorporation of the histone variants into nucleosomes may specify chromatin 
for particular biological roles (Malik and Henikoff, 2003; Talbert and Henikoff, 2010). 
In mammals, there are three major classes of histone H3 variants: the replicative histones 
H3.1 and H3.2, the replacement histone H3.3, and the centromeric protein A (CENP-A) 
(Loyola et al, 2007). The replicative variants H3.1 and H3.2 represent the bulk of the 
histones and are expressed and deposited mostly in a replication-coupled manner during S 
phase. The replacement variant H3.3 is expressed constitutively at low levels throughout 
the cell cycle and incorporated in a replication-independent (RI) manner. S.cerevisiae has 
only a single H3 variant, most closely related to H3.3 (Tagami et al, 2004 ; Nakatani et al., 
2004; Henikoff and Ahmad, 2005; Kamakaka and Biggins, 2005). CENP-A is a centromere 
specific form of the H3 and essential for centromere function in yeast and mammals (Black 
and Bassett, 2008).  
Histone H2A has the largest number of variants, including H2A.X, H2A.Z, macroH2A and 
H2A.Bbd. H2A.Z (Htz1 in yeast) is essential in mammals but not in yeast (Faast et al, 2001), 
and its deletion increases the need for chromatin remodeling enzymes to promote 
 15 
transcription (Santisteban et al, 2000). H2A.Z stabilizes the nucleosome and facilitates the 
formation of higher order structures (Park et al, 2004; Hoch et al, 2007; Fan et al, 2002), 
and is also required for the expression of genes that cluster near the sub-telomeric region 
where it has been proposed to act as a boundary element to stop the spread of 
heterochromatin (Meneghini et al. 2003; Raisner and Madhani, 2006). H2AX is similar to 
canonical H2A and is involved in the repair of DSBs as described above. In yeast there is 
no histone H2AX variant, but the major form of H2A is phosphorylated in a similar way and 
fulfils a similar role. (Shroff et al, 2004; Lydall and Whitehall, 2005). The functions of 
MacroH2A and H2A.Bbd are not fully understood. However, MacroH2A associates with 
repressive chromatin (Chakravarthy and Luger, 2006), whereas H2A.Bbd seems to be 
associated with transcriptionally active chromatin in mammals (Chadwich and Willard, 
2001).  
 
1.2.2.3 ATP-dependent chromatin remodeling enzymes 
 
ATP-dependent chromatin remodeling complexes (consisting of between 4 and 17 subunits) 
render DNA more accessible by weakening DNA-histone contacts, sliding nucleosomes 
along DNA, or removing H2A-H2B dimers from the nucleosome (Becker and Horz, 2002; 
Flaus and Owen-Hughes, 2004; Saha et al, 2006). Chromatin remodeling enzymes utilize 
the energy of ATP hydrolysis to alter the contacts of histones with DNA (van Vugt et al, 
2007). ATP-dependent chromatin remodeling enzymes possess a conserved Snf2 helicase 
domain that is capable of binding and hydrolyzing ATP (Eisen et al, 1995). They can be 
classified into four main families: Swi/Snf , Iswi, Ino80 and CHD. 
SWI/SNF: In addition to the Snf2 helicase domain, The Swi/Snf (mating type 
switching/sucrose non-fermenting) family proteins possess a bromodomain that binds 
acetylated histone tails (Marfella et al, 2007; Wang et al, 2007). Drosophila brahma (BRM), 
mammalian BRG1 (Brahma related gene 1) and yeast SNF2 are examples of proteins that 
belong to this family. Swi/Snf complexes function in various cellular processes such as 
DNA replication, repair and transcription (Wang et al, 2007). 
Iswi: the Iswi (imitation switch) family proteins possess a SANT (SWI3, ADA2, NCOR, 
TFIIIB) domain that binds histone tails (Marfella et al, 2007; Wang et al, 2007). The 
chromatin accessibility complex (CHRAC), nucleosome remodeling factor (NURF) complex 
and ATP-utilizing chromatin assembly and remodeling factor complex (ACF) are examples 
of the Iswi family (Tsukiyama(a) et al, 1995; Tsukiyama(b) et al, 1995; Varga-Weisz et al, 
1997; Ito et al, 1997). 
INO80: The Ino80 complex is reported to facilitate exonucleolytic resection, promote 
Ku70/80 recruitment and displace nucleosomes during a successful strand invasion event. 
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It also contributes to the cell-cycle checkpoint response. SRCAP (SNF2-related CREB-
activator protein) and p400 are examples of Ino80 (inositol requiring 80) family proteins in 
mammals. 
CHD: Like all ATP-dependent remodeling enzymes, CHD (Chromodomain helicase DNA 
binding) family proteins possess a conserved Snf2 helicase domain, and also a 
chromodomain that binds methylated lysines in the N-terminal tail of histone H3. 
 
1.2.2.4   Histone chaperone 
 
Histone chaperones deliver histones to the DNA during chromatin assembly, as well as 
remove histones from the DNA to facilitate chromatin disassembly, through binding to the 
positively charged histones and shielding their charge from the highly negatively charged 
DNA (Tyler et al, 2002). In budding yeast, several histone chaperones have been identified 
(Eitoku et al, 2008). Histone chaperones that bind preferentially to histones H3/H4 include 
Asf1, CAF-1 (chromatin assembly factor 1), HIR (histone regulator), Spt6 and Rtt106 (Emili 
et al, 2001; English et al, 2005; English et al, 2006; Green et al, 2005; Verreau et al, 1996; 
Tagami et al, 2004; Bortvin and Winston, 1996; Huang et al, 2005). Furthermore, FACT 
(facilitates chromatin transcription) (Orphanides et al, 1999), Nap1 and Vps75 can 
associate with all four core histones (Park et al, 2008; Andrew et al, 2008; Selth et al, 2009).  
 
1.3 Asf1 
 
CIA/Asf1 (cell cycle gene 1 (CCG1)-interacting factor A or antisilencing function 1) was first 
identified in a genetic screen based on its ability to disrupt transcriptional silencing in 
budding yeast when overexpressed (Le et al, 1997). Later, it was shown that Asf1 was a 
histone chaperone involved in both replication-coupled and replication-independent 
nucleosome assembly (Green et al, 2005; Tagami et al, 2004; Tyler et al, 1999). Asf1 is a 
highly conserved histone chaperone among eukaryotes that assembles and disassembles 
chromatin during transcription, replication and repair (Le et al, 1997; Tyler et al, 1999; 
Munakata et al, 2000; English et al, 2006). Although Asf1 is not required for viability in 
S.cerevisiae, it is essential in S. pombe, Drosophila, chicken and humans (Umehara et al, 
2002; Moshkin et al, 2002; Sanematsu et al, 2006; Groth et al, 2005). In mammals, there 
are two forms of Asf1, Asf1a and Asf1b, which appear to have common functions, as both 
proteins are present in the complexes co-purified with H3.1. However, they appear to have 
distinct functions in a replication-independent assembly pathway, since Asf1a interacts with 
HIRA, but Asf1b does not (Tagami et al, 2004).   
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Asf1 has a wide variety of functions in transcription, DNA replication and DNA repair (De 
Koning et al, 2007; Eitoku et al, 2008; Park and Luger, 2008; Sharp et al, 2001; Chimura et 
al, 2002; Adkins (a) et al, 2004; Korber et al, 2004; Schwabish et al, 2006; Williams et al, 
2008; Le et al, 1997; Tyler et al, 1999; Tagami et al, 2004; Das et al, 2009; Emili et al, 2001; 
Hu et al, 2001). Yeast deleted for ASF1 exhibit spontaneous DNA damage, display 
increased frequencies of genome rearrangements (Myung et al, 2003; Prado et al, 2004), 
and are sensitive to a number of genotoxic agents that damage DNA during replication 
(Tyler et al, 1999; Linger et al, 2005). This is physiologically significant because 
chromosome rearrangements are an important source of tumourigenic mutations and often 
arise through replication-linked DNA damage.  
  
1.3.1   Structure of Asf1   
 
The N-terminal domain containing 155 residues is the highly-conserved core region of Asf1. 
In contrast, the C-terminal tail is variable, unstructured and flexible (Daganzo et al, 2003; 
Mousson et al, 2005). In S.cerevisiae and S.pombe, the Asf1 C-terminal sequence is 
extremely rich in asparatates and glutamates and this type of tail is common in histone 
chaperones. In vertebrates, the Asf1 C-terminal sequences are not as rich in acidic 
residues, but they are phosphorylated by Tousled-like kinases. The major Tlks (Tousled-
like kinases) phosphorylation sites are located in the C-terminal part of Drosophila and 
human Asf1 within a (D/E)-N-S-(L/M) consensus motif, and both proteins cooperate in 
control of chromatin dynamics and cell cycle progression (Carrera et al, 2003; Sillje and 
Nigg, 2001; Mello et al, 2002). This phosphorylation by Tlk is inhibited by ATM/ATR/Chk1 
kinases in response to DNA damage (Silje and Nigg, 2001; Groth et al, 2003). The loss of 
Tlk activity or mutation of phosphorylation sites for Asf1 results in degradation of Asf1 by 
both proteasome-dependent and independent pathways (Pilyugin et al, 2009). 
The N-terminal domain of Asf1 consists of three helical linkers on top of a compact 
immunoglobulin-like β-sandwich fold. This domain is sufficient for all currently known 
functions of the full-length protein (Daganzo et al, 2003). Asf1 has a large electro-negative 
surface potential surrounding one side, and a highly conserved hydrophobic groove that 
interacts with histone proteins (Daganzo et al, 2003; Mousson et al, 2005). 
The 3D structure of the functional N-terminal domain of budding yeast was determined by 
X-ray crystallography (Figure 3a)(Daganzo et al, 2003). Florence Mousson and Françoise 
Ochsenbein determined the structure of the human Asf1a N-terminal domain by nuclear 
magnetic resonance spectroscopy (NMR) (Mousson et al, 2005). The structures of yeast 
and human Asf1 N-terminal domains are quite similar. Recently, the YEATS domain of 
yeast Yaf9 was shown to have a highly similar structure to Asf1. Yaf9 is a subunit of both 
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the NuA4 histone H4 acetyltransferase complex and the SWR1 remodeling complex (Wang 
et al, 2009). The authors suggested that Yaf9 may have a similar histone-binding capacity 
as Asf1. 
             b 
Figure 3. (a) Structure of the Asf1 N-terminal domain is well conserved. The superposition 
between hAsf1a (1-156) (purple) and S.cerevisiae Asf1(green) (Mousson et al, 2005; 
Daganzo et al, 2003). 
(b) Ribbon diagram model of the Asf1p N-terminal domain bound to heterodimer histone H3 
(cyano) and H4 (green) (English et al, 2006). 
 
Structure of the Asf1-H3/H4 complex 
 
This structure shows that Asf1 binds to a histone H3/H4 heterodimer (Fig 3b) (English et al, 
2006; Natsume et al, 2007). The hydrophobic groove of Asf1 binds the histone H3-H4 
heterodimer by enveloping the C-terminus helix of histone H3, thereby blocking the 
formation of a (H3-H4)2 heterotetramer. Furthermore, the C-terminus of histone H4, that 
forms a mini-β sheet with histone H2A in the nucleosome, undergoes a major 
conformational change upon binding to Asf1 and adds a β strand to the Asf1 β sheet 
sandwich (English et al, 2006; Natsume et al, 2007).  Additionally, the non-conserved acidic 
C-terminal tail of yeast Asf1 may strengthen the interaction between Asf1 and H3/H4 
(English et al, 2006; Daganzo et al, 2003).  
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1.3.2    Asf1 at the crossroads of chromatin and DNA checkpoint pathways  
 
Chromatin assembly occurs in a stepwise manner: a tetramer of histones H3/H4 is 
deposited first followed by two dimers of H2A/H2B on the outside of the tetramer (Verreault 
et al, 1996). Asf1 interacts with both CAF-1 and HIR and hands off histones to CAF-1 and 
HIRA facilitating replication-dependent and replication-independent chromatin assembly 
respectively (Krawitz et al, 2002; Nakatani et al, 2004; Green et al, 2005, Mousson et al, 
2007).  
 
1.3.2.1   Role for Asf1 in chromatin assembly/disassembly 
 
Replication-dependent chromatin assembly/disassembly 
 
The association of DNA with the histones in the nucleosome makes it difficult to access the 
DNA by protein molecules. The nucleosome is disassembled into two H2A-H2B dimers and 
a (H3-H4)2 tetramer ahead of the moving fork during DNA replication, transcription and 
repair. Then the parental histones are relocated behind the replication fork and the full 
nucleosome density is completed by the deposition of newly synthesized histones. (Tagami 
et al, 2004; Falbo and Shen, 2006; Groth et al, 2007). In S.cerevisiae, passage through S 
phase in the absence of core histone synthesis results in a loss of viability that cannot be 
rescued by re-expression of histones in G2 (Kim et al, 1988).  
The H2A-H2B chaperone FACT has been shown to be associated with the MCM 
(Minichromosome maintenance) helicase that unwinds DNA in front of the replication fork 
(Tan et al, 2006). Asf1 is also associated with the MCM helicase, suggesting that Asf1 
plays a role in disrupting parental nucleosomes and potentially transfering them onto the 
nascent DNA behind the fork (Groth et al, 2007). 
Asf1 acts in both chromatin assembly and disassembly (Adkins et al, 2004a,b; Adkins et al, 
2007; Korber et al, 2006). Yeast Asf1 and both human isoforms Asf1a and Asf1b can 
interact with CAF-1 p60, promoting replication-dependent chromatin assembly 
synergistically with CAF-1 (Figure 5c) (Verreault, 2000; Sharp et al, 2001; Krawitz et al, 
2002; Mello et al, 2002; Loyola and Almouzni, 2004). This pathway ensures that histones 
are promptly assembled onto newly replicated DNA to minimize the potential for DNA 
damage, as well as being important for inheritance of epigenetic information during DNA 
replication and repair (Ye et al, 2003; Groth et al, 2007; Henikoff et al, 2004). CAF-1 
associates with the replication forks through an interaction with proliferating cell nuclear 
antigen (PCNA), a component essential for DNA replication and DNA repair (Shibahara and 
Stillman, 1999; Zhang et al, 2000; Moggs et al, 2000).  
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CAF-1 is essential in humans, as depletion of p60 CAF-1 triggers apoptosis in proliferating 
cells (Nabatiyan and Krude, 2004). In contrast to human cells, Asf1 and CAF-1 are not 
essential for cell viability in S.cerevisiae, probably because of the existence of other 
chaperones for histone H3-H4, such as Rtt106 (Huang et al, 2005). Besides Asf1, CAF-1 
has been shown to mediate histone deposition onto DNA assisted by Rtt106 that binds to 
CAF-1 as well (Huang et al, 2005; Tyler et al, 2001). Although CAF-I is not essential in S. 
cerevisiae, its inactivation results in increased sensitivity to UV radiation and reduced 
silencing of genes adjacent to telomeric DNA (Kaufman et al, 1997).  
CAF-1 is an evolutionarily conserved complex. In both yeast and human cells, CAF-1 
consists of three subunits: Cac1, Cac2 and Cac3 in yeast ; p150, p60 and p48 in human 
cells; and p180, p105, p75 and p55 in Drosophila. The smallest subunit p55 binds the N-
terminal part of histone H4 via a β-propeller structure (Smith and Stillman 1989; Kaufman et 
al, 1995; Kaufman et al, 1997; Song et al, 2008). 
Asf1N binds a B domain motif found in both the p60 subunit of CAF-1 and HirA  (Mello et al, 
2002; Sanematsu et al, 2006; Tyler et al, 2001) (Figure 5b). CAF-I and HirA thus compete 
for binding to the same surface of Asf1N that is distinct from the surface of Asf1N that binds 
H3/H4 (Malay et al, 2008). 
 
a       b  
c 
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Figure 4. A view of H3.1-H4 deposition by CAF-1. (a) The structure of Asf1-H3/H4 complex 
shows two binding sites for human ASFa on the histone dimer. Orange triangle indicates 
CAF-1-binding site. (b) Interaction of yeast Asf1 (SpAsf1) with a peptide from the p60 
subunit of CAF-1, spCac2 (Malay et al, 2008). (c) Both Asf1a and Asf1b act as histone 
donors for CAF-1, promoting H3.1 deposition (De Koning et al, 2007). 
 
Replication-independent chromatin assembly 
 
Outside the S phase, histones can be deposited onto DNA by HIRA (HIR complex in S. 
cerevisiae) via a replication-independent pathway (Henikoff and Ahmad, 2005). The 
interaction between Asf1 and Hir was initially found in budding yeast and Asf1 can copurify 
with all four subunits of HIR (Hir1, Hir2, Hir3 and Hpc2). This interaction is necessary for 
telomeric silencing (Sharp et al, 2001; Daganzo et al, 2003; Green et al, 2005). Similarly, 
Asf1 forms complexes with histones H3 and H4 as well as HIRA in humans (Figure 4c). 
HIRA preferentially deposits the histone replacement variant H3.3 in nucleosomes (Loppin 
et al, 2005; Nakayama et al, 2007; Tagami et al, 2004; Van der Heijden et al, 2007). Since 
H3.3 is predominantly incorporated into actively transcribed genes (Mito et al, 2005; 
Schwartz et al, 2005; Wirbelauer et al, 2005), the HIRA/ASF1a complex is thought to 
mediate transcription-coupled deposition of histone H3.3 (Henikoff et al, 2008; Nourani et al, 
2006; Prather et al, 2005; Ray-Gallet et al, 2002; Tagami et al, 2004). The overexpression 
of HIRA can also inhibit histone expression and lead to an S-phase arrest (Nelson et al, 
2002). 
The human Asf1 N-terminal domain has been shown to interact with the B-domain of HIRA 
(Daganzo et al, 2003; Zhang et al, 2005) in the form of an antiparallel β-hairpin (Tang et al, 
2006) (Figure 4b). The evolutionarily conserved B-domain of HIRA (425-472) is located in 
the central portion of the protein. This surface is located on the opposite side of the H3 
binding site of Asf1 (Tang et al, 2006). The ASF1 D37R+E39R double mutant disrupts the 
ASF1a-HIRA interaction, but does not affect the ASF1a-H3 complex (Daganzo et al, 2003; 
Tang et al, 2006; Mousson et al, 2005).  
 22 
            a            b  
c   
Figure 5. A view of H3.3-H4 deposition by HIRA. (a) The structure of Asf1-H3/H4 complex 
shows two binding sites for human ASFa on the histone dimer. Orange triangle indicates 
HIRA-binding site. (b) hAsf1a-HIRA Ribbon diagram of a HIRA B domain peptide (green) 
bound to hAsf1a N-terminal domain (gray) (Tang et al, 2006). (c) Asf1a cooperate with 
HIRA to deposit H3.3. 
 
1.3.2.2   Asf1 and DNA damage checkpoint pathway 
 
Asf1 promotes genomic stability and protects against DNA damage and replication stress 
(Mousson et al, 2007). Asf1 participates in the regulation of the DNA damage checkpoint 
pathway by interacting with the central checkpoint kinase Rad53. Additionally, Asf1 is 
required for histone H3K56 acetylation during DNA repair. 
 
Asf1 and Rad53 
 
Asf1 is important for genomic stability, since cells lacking Asf1 are sensitive to agents that 
cause DNA damage or replication stress, such as methyl methane sulfonate (MMS), 
hydroxyurea (HU), camptothecin (CPT), bleomycin and cisplatin (Emili et al, 2001; Hu et al, 
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2001; Mousson et al, 2005; Ramey et al, 2004; Tamburini et al, 2005). HU treatment 
inhibits the ribonucleotide reductase (RNR) and leads to depletion of dNTPs and stalling of 
DNA replication (Elledge et al, 1992; Slater et al, 1973). MMS methylates DNA bases and 
can indirectly lead to the presence of abasic sites as well as single- and double-strand 
breaks in DNA. CPT is an interfacial inhibitor of DNA topoisomerase I that stabilizes the 
covalent complex formed by DNA topoisomerase I when it relaxes DNA by cleaving one 
DNA strand. DSBs are formed when the replication machinery collides with the CPT-
stabilized complex of DNA topoisomerase I bound to the DNA (Pommier et al, 2003).  
Yeast Asf1 forms a complex with Rad53 in the absence of genotoxic stress. A part of the 
Rad53-Asf1 interaction is mediated by the FHA1 domain of Rad53 binding to a 
phsophorylated form of Asf1 (Schwartz et al, 2003). The Asf1-Rad53 complex was 
reportedly dissociated when yeast cells were subjected to genotoxic stress in a Mec1-
dependent manner (Emilie et al, 2001; Hu et al, 2001). It was suggested that the 
phosphorylation sites of Rad53 induced by DNA damage could inhibit the Asf1-Rad53 
interaction. These observations suggested that activation of Rad53 and liberation of Asf1 
may be an important cellular response to DNA damage acting perhaps at the level of 
chromatin assembly (Emili et al, 2001; Hu et al, 2001). However, in mammalian cells, Asf1 
does not interact with Chk2 (homologue of Rad53), but rather with Tlk kinases that are not 
conserved in yeast (Shillje and Nigg, 2001). The Tlk kinases phosphorylate C-terminal 
sequences of Asf1 during S phase, and this phosphorylation is inhibited in response to 
genotoxic stress. The functional significance of this phosphorylation is poorly understood, 
although there is some data suggesting that phosphorylation can affect the half-life of Asf1 
isoforms. 
 
Asf1 and H3K56Ac 
 
Acetylation of H3K56 is an abundant modification of all newly synthesized H3 in budding 
yeast, fission yeasts and in Tetrahymena thermophilus (Masumoto et al, 2005; Garcia et al, 
2007; Xhemalce et al, 2007), but is much less abundant in mammalian cells (Jasencakova 
et al, 2010). H3K56 is located at the DNA entry/exit point on the nucleosome core (Davey 
et al, 2002). Although H3K56 acetylation does not appear to greatly alter the overall 
structure of the nucleosome, acetylation at this residue increases the plasticity of 
nucleosomes, which may facilitate access of necessary protein factors to the DNA 
(Neumann et al, 2009; Watanabe et al, 2010). 
H3K56Ac is involved in the response to DNA damage during replication (Collins et al, 2007; 
Driscoll et al, 2007; Han et al, 2007a,b,c; Masumoto et al, 2005; Tsubota et al, 2007). In 
yeast, H3K56ac peaks during S phase where it plays a role in the DNA damage response 
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and is largely deacetylated by the Sir2-related HDACs Hst3 and Hst4 during the G2/M 
phase of the cell cycle (Masumoto et al, 2005; Han et al, 2007a,b,c; Chen et al, 2008; Zhou 
et al, 2006; Celic et al, 2006; Maas et al, 2006).  
H3K56 acetylation is catalyzed by Rtt109 (also known as KAT11) in S.cerevisiae and 
Schizosaccharomyces pombe (Xhemalce et al, 2007; Schneider et al, 2006; Tsubota et al, 
2007; Han et al, 2007a,b,c; Driscoll et al, 2007; Allis et al, 2007), and by CBP/p300 and/or 
Gcn5 in mammalian cells (Das et al, 2009; Tjeertes et al, 2009). In addition to sensitivity to 
genotoxic stress, cells lacking the H3K56 acetyltransferase Rtt109 or cells expressing H3 
with K56 mutated to arginine (H3K56R) exhibit an increased frequency of spontaneous 
chromosome breaks (Allis et al, 2007; Driscoll et al, 2007; Han et al, 2007a,b,c). Rtt109 
harbors very low acetyltransferase activity on its own (Driscoll et al, 2007; Tsubota et al, 
2007), but its activity is strongly stimulated by either Asf1 or Vps75 (Albaugh et al, 2010; 
Berndsen et al, 2008; Han et al, 2007c; Collins et al, 2007). Asf1 physically interacts with 
Rtt109 and is absolutely required for H3K56 acetylation. Vps75 also interacts with Rtt109 to 
promote H3K56ac. However, the accumulation of H3K56ac in vivo is dependent on Rtt109 
and Asf1, but not Vps75. The asf1Δ or rtt109Δ mutants lack H3K56 acetylation, but no 
decrease was observed in cells lacking Vps75 (Tsubota et al, 2007; Schneider et al, 2006; 
Recht et al, 2006; Selth and Svejstrup, 2007). 
H3K56 acetylation is required for S-phase chromatin assembly and was proposed to be a 
critical signal for turning off the DNA damage checkpoint following DNA repair followed 
(Chen et al, 2008), although this latter claim is controversial (Kim and Haber, 2009). H3K56 
acetylation can increase the binding affinity between H3-H4 with CAF-1 and Rtt106 to 
promote efficient deposition of H3-H4 onto replicating DNA by these two histone 
chaperones (Li et al, 2008). 
H3K56Ac is also involved in DSB repair. The mutations affecting H3K56Ac lead to 
increased sensitivity to agents that cause DSBs. The persistence of K56 acetylation when 
DSBs are present is due to the presence of DNA damage checkpoint proteins, and may be 
important for replication fork progression in the presence of DNA damage. (Chen et al, 
2008). 
Asf1 is thought to maintain the integrity of the replisome through H3K56 acetylation. Asf1 
has been shown to directly interact with origins of replications and can also associate with 
components of the replisome (Groth et al, 2007; Han et al, 2007c). Indeed, in absence of 
Asf1 or H3K56 acetylation, components of the replisome are lost upon HU treatment 
(Franco et al, 2005; Han et al, 2007c).  It appears that Asf1 and H3K56 acetylation promote 
the stability of stalled replications forks, contributing to cellular survival upon replication 
stress. 
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1.3.2.3   Transcriptional regulation by Asf1 
 
In yeast, Asf1 facilitates chromatin disassembly at the PHO5 promoter to promote 
transcriptional activation, suggesting that it acts as a histone acceptor (Adkins and Tyler, 
2004). Asf1 travels with the transcription machinery and/or rapidly fills in gaps left in 
nucleosome arrays following passage of RNA polymerase (Schwabish et al, 2006). The 
nature of Asf1 as an interactor with the TFIID subunit Bdf1 also suggests its participation in 
transcription control at various RNA polymerase II-dependent gene loci (Chimura et al, 
2002; Zabaronick and Tyler, 2005). Asf1 is also involved in developmental gene expression 
control by mediating transcriptional repression of NOTCH target genes in Drosophila 
(Goodfellow et al, 2007).  
In yeast, the loss of Asf1 results in impaired cell proliferation and minor defects of gene 
silencing at telomere and silent mating loci HMR and HML. These effects are greatly 
enhanced by inactivation of CAF-1, but not Hir (Tyler et al, 1999; Sharp et al, 2001; Krawitz 
et al, 2002). Asf1 and Hir participate together in a pathway for telomeric silencing that is 
independent of a pathway dependent on CAF-I (Daganzo et al, 2003). 
In addition, Asf1 was found to mediate histone H3 eviction and deposition during 
transcriptional elongation. Furthermore, Asf1 has been implicated in transcription-
dependent, replication-independent histone H3 exchange at promoters, another process 
which can deposit K56-acetylated H3. 
 
1.3.2.4   Asf1 and histone modification 
 
Asf1 can affect the PTM state of histones. In addition to its role in promoting H3-K56-
acetylation described above, Asf1 also contributes to the acetylation of H3K9 and can 
promote trimethylation of H3K36 by Set2 in yeast (Adkins et al, 2007b; Lin et al, 2010). In 
human U2OS cells, histones bound to Asf1 showed two typical chromatin marks: H4K16Ac 
and H3K9Me3, giving rise to the hypothesis that Asf1 handles both new and parental 
histones during DNA replication (Groth et al, 2007).  
 
1.4. DNA damage Checkpoints 
 
Checkpoints were defined as molecular signaling cascades that trigger cell-cycle delay or 
arrest in response to DNA damage, providing sufficient time for repair from the damage 
(Hartwell et al. 1989). The DNA damage checkpoints control all the cell cycle phases in 
response to DNA damage. This damage results from the effect of exogenous mutagens, 
such as UV light, ionizing irradiation or chemical compounds, as well as spontaneous 
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damage that can arise from endogenous reactive oxygen species, or due to difficultes 
encountered during genomic DNA replication. If not repaired by continuously active repair 
pathways, DNA damage will lead to base mutations or single and double-strand chain 
breaks (Sancar et al, 2004). The DNA damage checkpoint cascades are evolutionarily 
conserved in eukaryotic organisms (Paulovich and Hartwell, 1995; Zhou and Elledge, 2000). 
 
1.4.1 DNA damage checkpoint proteins and checkpoint pathway 
 
 
Table 1. The proteins involved in the DNA-damage checkpoints and their orthologues 
(Harrison et al, 2006). 
 
Checkpoint signaling consists of damage sensors, transducers and effectors (Ellege 1996). 
The sensors recognize the damaged DNA and initiate the signaling response. Transducers 
can be activated by the DNA damage signal passed from the sensors, then amplify the 
damage signal by phosphorylating downstream effectors. Finally, the effectors excute the 
regulation of different cellular processes.  
DNA checkpoint pathways are conserved in eukaryotes and require a family of 
serine/threonine protein kinases which show strong similarity to the lipid kinase 
phosphatidyl-inositol-3-kinase (PI3K). Mec1 and Tel1 in budding yeast and their 
homologues Ataxia-Telangectasia Mutated (ATM), Ataxia-Telangectasia Related (ATR) and 
DNA-PK in humans are members of this family (Harrison and Haber, 2006). Other 
downstream kinases are also conserved and consist of Chk1 and Rad53 in budding yeast, 
Chk1 & Chk2 in vertebrates, Chk1 & Cds1 in fission yeast (Harrison, 2006). 
In the presence of exogenous DNA-damaging agents or replication inhibitors, the exposure 
 27 
of ssDNA at DSBs or at stalled replication forks is essential for activation of the DNA 
damage checkpoint. Single-strand DNA may be generated at stalled forks by the continued 
unwinding of DNA by MCM helicases ahead of the stalled replication fork (Sogo et al. 2002; 
Byun et al. 2005; Nedelcheva et al. 2005). The ssDNA is subsequently bound by RPA. The 
RPA-coated ssDNA, a structure commonly found after replicative stress or as a DNA repair 
intermediate, is critical for Mec1-Ddc2 recruitment. (Rouse and Jackson 2002; Zou and 
Elledge, 2003; Harrison and Harber, 2006; Branzei and Foiani, 2008).  
 
Activation of PIKK family members also depends on other DNA damage sensors, such as 
the PCNA-like Ddc1-Mec3-Rad17 complex and the Rad24-Rfc2-5 alternative replication 
(RFC) complex. The budding yeast Ddc1-Mec3-Rad17 complex is a PCNA-like checkpoint 
clamp (orthologous to the human 9-1-1 complex) that was shown to be loaded onto the 
single- and double-stranded DNA junction of stalled replication forks by the clamp loader 
Rad24-RFC complex (Kondo et al, 2001; Melo et al, 2001; Majka et al. 2003). The Ddc1-
Mec3-Rad17 complex stimulates the kinase activity of Mec1 (Majka et al, 2006), and Mec1 
phosphorylates the Rad24 subunit of the clamp loader and the Ddc1 and Mec3 subunits of 
the clamp. Interestingly, it was shown that the co-localization of the Ddc1-Mec3-Rad17 
complex and Mec1-Ddc2, is sufficient to activate Mec1 even without induced DNA damage 
(Bonilla et al, 2008). 
Mec1 is an essential phosphatidylinositol 3-kinase-like kinase (PIKK) that associates with 
the DNA binding protein Ddc2 to form a checkpoint sensor complex (Paciotti et al, 2000). 
The phosphorylation of RPA may be required for later steps in the checkpoint cascade 
through interaction with other checkpoint proteins, or maybe required for the dissociation 
from DNA (Bartrand et al, 2004; Harrison and Haber, 2006). After binding to ssDNA, Mec1 
functions in activating the checkpoint signal cascade via phosphorylation of the tranducer 
proteins Rad9 and Mrc1, and subsequent phosphorylation of the essential checkpoint 
effector kinase Rad53 (Branzei and Foiani, 2006). Rad53 is hyperphosphorylated and 
activated in response to DNA damage or DNA replication stress (Sun et al. 1996; Sanchez 
et al. 1996). Rad53 mutants are hypersensitive to genotoxic stress (Allen et al. 1994; Sun 
et al. 1996; Pellicioli et al. 1999). Activated Rad53 is critical for cellular processes through 
its downstream targets.  
Another pathway involves the PIKK kinase Tel1 (ATM). Compared to Mec1 (ATR), Tel1 
plays a minor role in response to DSBs in yeast. Deletion of TEL1 results in telomere 
shortening (Smogorzewska and de Lange, 2004), but does not show obvious checkpoint 
signalling defects or increased sensitivity towards DNA damage agents (Morrow et al, 
1995). Instead of using Ddc2, Tel1 binds to DNA through its association with the MRX 
complex (Mre11-Rad50-Xrs2). In the presense of DSBs, Tel1 can activate the DNA 
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damage checkpoint pathway  when Mec1 is absent (Nakada et al, 2003). Tel1 can respond 
to DSBs in a Mec1-dependent and –independent manner. In the Mec1 dependent manner, 
Tel1 is considered to contribute to DNA resection and produce ssDNA by activating an 
exonuclease that may correspond to MRX (Mantiero et al, 2007).  
In contrast to budding yeast, both ATM and ATR have important functions in the checkpoint 
response in mammalian cells and are thought to be activated by different kinds of DNA 
damage. ATM is specially involved in the reponse to unprocessed DSBs, whereas ATR 
apprears to be activated by processed DSB ends, replicative stress and intermediates of 
DNA repair pathway (Jazayeri et al, 2006; Longhese et al, 2006). 
Chk1 primarily contributes to the cell cycle arrest response to DNA damage in budding 
yeast, while Rad53 is more widely responsible response to DNA damage and replication 
stress. Chk1 has a major role in metazoan checkpoints, but a minor role in budding yeast. 
 
 
Figure 6. DNA damage checkpoint pathways in S.cerevisiae (Harrison et al. 2006). Black 
arrows indicate protein kinase phosphorylations of several target proteins that activate 
downstream events, whereas a black line terminated in a bar indicates an inhibitory 
modifications. Grey arrows indicate protein interactions that facilitate checkpoint activation. 
 
1.4.2 Downstream targets 
 
The DNA checkpoint pathways are involved in cell cycle progression, DNA repair, DNA 
replication fork stabilization, DNA replication origin firing, chromatin remodeling, 
transcription of DNA damage response genes, and induced apoptosis and senescence 
(Zhou et al. 2000; Shiloh Y 2003; Abraham RT 2001; Bartek and Lukas, 2001; Santocanale 
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and Diffley 1998; Shirahige et al. 1998; Foiani et al. 2000; Nyberg et al. 2002; Tercero et al. 
2003). 
 
1.4.2.1 Cell cycle arrest  
 
In response to DNA damage, checkpoints delay or arrest the cell cycle to provide sufficient 
time for repair. The phase of the cell cycle where the damage occurs determines the 
specific response. DNA damage checkpoints include G1/S checkpoints that delay or block 
cells before entry into S phase and S-phase and G2/M checkpoints that delay or block cells 
before the entry into mitosis (G2 in most organisms, but pre-anaphase in budding yeast). 
The G1/S checkpoint recognizes DNA damage during G1 phase and inhibits entry into S 
phase. The S-phase checkpoint/replication checkpoint, which is activated by DNA damage 
or impeded replication forks during S-phase, is crucial for stabilizing stalled replication forks 
and regulating late origin firing. The G2/M checkpoint prevents cells from initiating mitosis in 
the presence of damage to ensure that damaged chromosomes do not undergo 
chromosomal segregation during mitosis (Nyberg et al, 2002).  
Pds1, a yeast securin, is required for normal cell cycle arrest in response to DNA damage 
(Cohen-Fix et al, 1997; Yamamoto et al, 1996). After DNA damage, Pds1 is 
hyperphosphorylated in a Mec-1, Rad9-, Chk1-dependent, but Rad53-independent manner 
(Cohen-Fix et al, 1997). At the entry into mitosis, this checkpoint-dependent 
phosphorylation prevents its degradation by ubiquitination by Cdc20/ APC (Anaphase 
Promoting Complex) (Agarwal et al, 2003; Sanchez et al, 1999). However, Rad53 inhibits 
mitotic exit. Rad53 is required to maintain CDK activity during the checkpoint arrest likely 
through inhibition of Cdc5 (Cheng et al, 1998; Sanchez et al, 1999). Cdc5 inhibits the 
Bub2/Bfa1 complex which in turn inhibits the mitotic exit network (MEN) (Geymonat et al, 
2003; Hu et al, 2002; de Bettignies and Johnston, 2003). Rad53-dependent inhibition of 
Cdc5 could therefore inhibit progression through mitosis and help maintain the checkpoint 
arrest.  
 
1.4.2.2 Transcriptional response and regulation of RNR 
 
Dun1, a kinase downstream of Mec1/Rad53, was originally identified as a mutant deficient 
in the transcriptional induction of genes after DNA damage (Zhou and Elledge, 1993). Dun1 
is recruited to activated Rad53 through the Dun1 FHA domain (Bashkirov et al, 2003), and 
then activated by Rad53 dependent phosphorylation of the Dun1 activation loop (Chen et al, 
2007). Dun1 inhibits the transcriptional repressor Crt1 by phophorylation to prevent Crt1 
binding to DNA, resulting in the up-regulation of several genes involved in DNA repair or 
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dNTP biosynthesis, including the RNR3 gene encoding a large subunit of the ribonucleotide 
reductase and the HUG1 gene encoding a small protein of unknown function (Elledge et al, 
1992; Basrai et al,1999). DNA damage induced activation of Dun1 increases RNR activity 
by derepressing RNR gene transcription and by targeting by phosphorylation the RNR 
inhibitor Sml1 for proteolytic degradation (Zhao and Rothstein, 2002). Dun1 thus controls 
both the abundance and the activity of ribonucleotide reductase. The lethality of both MEC1 
and RAD53 deletion can be suppressed either by deletion of SML1 or by overexpression of 
RNR large subunit genes (Zhao et al, 1998; Desany et al, 1998). These results indicate that 
Mec1 and Rad53 are important for increasing the synthesis of dNTPs. Additionally, Rad53 
phosphorylates Swi6 that is a subunit of transcription factor SBF/MBF (Sidorova et al. 
1997). This phosphorylation is thought to contribute to the delay in G1 after DNA damage. 
 
1.4.2.3 Histone modification 
 
As highlighted above, the rapid phosphorylation of serine 129 on histone H2A (γH2AX) is 
induced by DNA damage in a Mec1 and Tel1-dependent manner. γH2A is important for 
amplifying the checkpoint response in mammalian cells via recruitment of the checkpoint 
mediator Mdc1 (Su, 2006) and maintaining high checkpoint activity in yeast (Keogh et al, 
2006). γH2A is also required for the recruitment of both the INO80 and SWR1 ATP-
dependent chromatin remodeling complexes, as well as cohesins to DSBs. Mec1/Tel1 also 
phosphorylates Ino80. 
When cells are exposed to genotoxic stress, Mec1-dependent downregulation of the Hst3 
and Hst4 deacetylases lengthens the persistence of H3K56ac in chromatin (Maas et al, 
2006, Thaminy et al, 2007, Masumoto et al, 2005). In addition, Rad9 binds H3K79-me3 in 
budding yeast. Removal of Rad9 from methylated histone leads to increased resection 
activity and partially bypasses the requirement for CDK activation of DSB processing 
(Lazzaro et al, 2008). 
 
1.4.2.4 Activation of DNA repair  
 
Different kinds of lesions require different repair pathways. The checkpoint pathway 
facilitates and induces DNA repair mechanisms (Harrison and Haber, 2006; Nyberg et al, 
2002). So far, the data are not sufficient to define specific mechanisms. However, the 
activities of at least some DNA repair proteins are modified after DNA damage in 
S.cerevisiae. Several DNA damage checkpoint proteins contain tandem BRCT (BRCA1 
carboxyl terminus) domains, a known phosphopeptide binding motif that is common among 
checkpoint and repair proteins (Glover et al, 2004). These proteins, such as BRCA1 and 
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BRCA2 in mammalian cells, are involved in DSB repair, and deficiencies in these proteins 
result in increased genomic instability (Hoeijmakers, 2001). 
DSBs are potentially lethal lesions because segregation of chromosomes in the presence 
of un-repaired DSBs can result in the loss of large amounts of genetic information. DSBs 
can be induced by endogenous free oxygen radicals, collapsed replication forks, or by the 
physical force generated when dicentric or catenated chromosomes are pulled to opposite 
poles during mitosis (Acilan et al, 2007). DSBs are also produced exogenously when cells 
are exposed to DNA damaging agents, such as ionizing radiation (IR), chemical agents 
such as chemotherapeutics that poison topoisomerase I or topoisomerase II (Degrassi et al, 
2004), or UV light that creates pyrimidine dimers and crosslinks (Limoli et al, 2002; Bosco 
et al, 2004).  
DSB repair is carried out by two major pathways: non-homologous end joining (NHEJ) and 
homologous recombination (HR) (Haber et al, 2000). HR can be further subdivided into 
gene conversion and single strand annealing (SSA). HR, which occurs mainly during late S-
G2 phase, takes advantage of sequence homology from an undamaged sister chromatid or 
homologous chromosome to repair the lesion with high ﬁdelity. NHEJ, that involves 
processing and ligation of broken DNA ends, is the major pathway for repairing non-
replication-associated breaks and occurs predominantly in the G1 phase of the cell cycle 
(Daley et al, 2005). The tightly packaged chromatin structure impedes DNA repair and the 
current DNA repair model on chromatin is: access-repair-restore (Smerdon et al, 1991).  
The phosphorylation of various repair factors is dependent on DNA damage checkpoints. In 
budding yeast, the checkpoint kinases have been shown to phosphorylate and regulate the 
recombination factors Srs2, Rad55 and Slx4 (Liberi et al, 2000; Bashkirov et al, 2000; Flott 
et al, 2007). Srs2, a DNA helicase/translocase, influences various steps of the 
recombination process by removing Rad51 from DNA. It is not known whether checkpoint-
dependent Srs2 phosphorylation influences its role in recombination, however, it was 
proposed that Srs2 might be involved in removing checkpoint proteins from DBSs after 
repair to resume cell cycle progression (Vaze et al, 2002). The recombination protein 
Rad55, a Rad51 paralog, is phosphorylated by Mec1 upon DNA damage and this 
modification may play a role in activating recombinational repair (Bashkirov et al, 2000; 
Herzberg et al, 2006). Mec1/Tel1-dependent phosphorylation of Slx4 also controls the 
single-strand annealing (SSA) sub-pathway of DSB repair (Flott et al, 2007). Rtt107 is 
implicated in Mms2-dependent DNA repair during S phase, and its phosphorylation by 
Mec1 requires Slx4 (Rouse, 2004; Roberts et al, 2006). Nej1 phosphorylated by Dun1 has 
been shown to effect NHEJ (Ahnesorg and Jackson, 2007). 
In S.cerevisiae, a mutation in Rad24 that affects activation of the Mec1-dependent pathway 
slowed down the kinetics of DSB resection and promoted ectopic recombination with short 
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homologous donor sequences (Aylon ad Kupiec, 2003). In fission yeast, the 
phosphorylation of Crb2 (a putative Rad9 ortholog) by CDK1 is important to mediate later 
steps of HR implicating the RecQ helicase Rqh1 and the Top3 topoisomerase (Caspari et 
al, 2002). 
 
1.4.2.5 S-phase specific downsteam targets 
 
During DNA replication, a DNA lesion caused by stresses such as UV damage, oxidative 
damage, genotoxic drugs or growth medium deprivation may slow down or even arrest 
progression of the replication fork. HU depletes the cellular dNTP pool and causes 
replication fork stalling. MMS also slows fork progression (Tercero and Diffley, 2001). MMS 
was found to inhibit replication fork progression independently of checkpoint kinases, but 
the inhibition of late origin firing is dependent on Mec1 and Rad53 activation.  
 
Role of replication checkpoint in stabilizing stalled replication forks 
 
The replication checkpoint is required to stabilize stalled replication forks to prevent their 
collapse and promote their restart (Longhese et al, 2003). Fork collapse can often result in 
DSBs, chromosomal rearragements and genomic instability (Branzei and Foiani, 2005). 
Cells lacking MEC1 or RAD53 are subject to irreversible collapse of stalled replication forks 
(Tercero et al. 2001). Many replication proteins dissociate from the stalled replication forks 
in the absence of the replication checkpoints (Blow et al. 2005; Cobb et al. 2003; Lucca et 
al. 2004). The replication checkpoints may stabilize the stalled replication fork by 
phosphorylating components of the replication fork, such as RPA, DNA polymerase α, 
Mcm2-7, Exo1 and Esc4/Rtt107 (Brush et al, 1996; Pellicioli et al, 1999; Cobb et al. 2003; 
Cobb et al, 2005; Cotta-Ramusino et al, 2005; Segurado and Diffley, 2008; Chin et al, 
2006). These phosphorylations may prevent the collapse of arrested forks and the 
formation of abnormal replication intermediates, including DSBs. However, the targets of 
Rad53 and Mec1 that are important in preventing replication fork collapse have not yet 
been identified. MMS also slows fork progression as mentioned above. Cells lacking Mec1 
are more sensitive to MMS than cells lacking Rad53, which suggests that Mec1 can 
stabilize stalled forks at least partly independently of Rad53 (Tercero et al. 2001). 
Rad53 inhibits the exonuclease Exo1 by phosphorylation. Deletion of EXO1 can rescue the 
MMS, UV and IR, but not HU, sensitivity of rad53 mutants (Segurado et al, 2008). Thus, 
Exo1 is an important target of Rad53 in the cellular response to MMS, UV, and IR.  
Additionally, Mrc1 is phosphorylated in a checkpoint-dependent manner. Mrc1 is associated 
with the replication fork and is required for normal replication fork progression, but also is 
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involved in preventing continued replisome progression at stalled forks. Mrc1 binds to the 
Tof1-Csm3 complex at stalled replication forks to prevent the uncoupling of the replication 
machinery components such as polymerases, MCMs and Cdc45 (Nedelcheva et al. 2005). 
Mrc1, Csm3 and Tof1 are presumed to act as a bridge to regulate the progression of DNA 
unwinding with DNA synthesis. Mrc1 can bind to Pol2, which is a catalytic subunit of the 
leading strand polymerase. This binding is regulated by checkpoint-dependent 
phosphorylation of Mrc1 (Lou et al. 2008). Mrc1 also interacts with the Mcm6 helicase when 
cells are treated by MMS (Komata et al. 2009). Decreasing the amount of Mcm2-7 complex 
available for loading at dormant origins results in slower replication rates and decreased 
viability (Ge et al, 2007). 
 
 
 
Figure 7. Replication checkpoint response at the replication fork (Segurado et al, 2009). 
When replication forks hit DNA lesions or stall because of dNTP deprivation, the effector 
kinase Rad53 is phosphorylated and activated. Rad53 maintains stable, functional DNA 
replication forks, inhibits firing of late origins, activates gene expression and prevents entry 
into mitosis and unscheduled recombination. 
 
Control of late origin firing 
On each eukaryotic chromosome, DNA synthesis begins at origins of replication found at 
hundreds or thousands of sites. The first origins of replication were identified in budding 
yeast. The regulation of origin initiation or “firing” is strongly conserved across evolution 
(Bell and Dutta 2002). Most cell types have a temporal programme of origin activation 
whereby origins fire in a continuum throughout S-phase, such as early and late firing origins. 
The replication checkpoints regulate DNA synthesis by inhibiting late origin firing. The early 
origins must fire to elicit the checkpoint response and the checkpoints inhibit the firing of 
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late or dormant origins in response to DNA damage (Santocanale et al. 1998, Santocanale 
et al. 1999, Shirahige et al. 1998). The checkpoint blocks origin firing by inhibiting the 
transition of the pre-replicative complex (preRC) to the preinitiation complex (preIC). The 
preRC contains an inactive form of the Mcm2-7 helicase loaded at origins through the 
action of the ORC complex, Cdt1, and the Cdc6 ATPase. At the G1/S transition, CDKs 
(cyclin-dependent kinases) and DDK (Dbf4-dependent kinase) must be activated to 
promote the transition to the preIC containing Mcm10, Cdc45, GINS, Sld2, Sld3, and 
Dpb11. In budding yeast, recent studies have shown that Rad53 phosphorylates directly 
Sld3 and Dbf4 to inhibit the CDK and DDK pathway respectively to block late origin firing. 
Sld3 and the Cdc7-Dbf4 kinase complex are required for DNA replication initiation (Tanaka 
et al. 2007; Bousset et al. 1998; Zegerman et al. 2010; Lopez-Mosqueda et al. 2010). The 
DNA damage checkpoints (ATM, ATR, Chk2, Chk1) also inhibit late origin firing in 
mammalian cells (Santocanale and Diffley, 1998; Shirahige et al, 1998; Dimitrova and 
Gilbert, 2000; Zachos et al, 2003; Bartek et al, 2004). ATM/Chk2 phosphorylates and 
destabilises Cdc25A, which prevents Cdk2 phospho-tyrosine dephosphorylation, thereby 
preventing Cdk2 activation and blocking DNA synthesis (Falck et al, 2001). Replication 
stress activates ATR and Chk1, which regulate initiation by controlling Cdc45 assembly at 
replication origins (Apricio et al, 1999; Costanzo et al, 2000; Liu et al, 2006). The frequency 
of origin usage in clusters of early origins might also be negatively regulated by the ATR 
pathway, through a lateral inhibition of activated origins on the potential neighbouring 
origins (Mechali 2010). 
 
Figure 8. Checkpoint control of replication origins firing (Mechali 2010). The checkpoint 
signalling through ATR results in the inhibition of late origins. The frequency of origin usage 
in clusters of early origins might also be negatively regulated by the ATR pathway, through 
a lateral inhibition of activated origins on the potential neighbouring origins. 
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1.4.3 DNA damage checkpoint inactivation: recovery and adaptation 
 
Recovery and adaptation correlate with the disappearance of phosphorylated Rad53, 
largely due to the function of Ser/Thr phosphatases (Heideker et al, 2007). Once DSB 
repair is complete, the DNA damage checkpoints are reversed so that cells can resume cell 
cycle progression by «checkpoint recovery» (Bartek and Lukas, 2007). The mechanism of 
checkpoint recovery is unknown, although several proteins have been identified to play a 
role in this process so far, including Rad51 and the DNA helicase Srs2 (Vaze et al, 2002; 
Krejci et al, 2003). 
Cells can also turn off the DNA damage checkpoint in the absence of DNA repair by 
«adaptation» (Bartek and Lukas, 2007). Although the pathway is not fully elucidated, it was 
shown to involve several several proteins including Cdc5, the phosphatases Ptc2/3 as well 
as casein kinase 2 (CK2) and the NHEJ protein Ku complex (Lee et al, 1998). 
Ptc2/3 and CK2 play a role in adaptation and recovery. Ptc2/3 phosphatases are required 
for the DNA checkpoint inactivation, but only in response to DSBs such as that induced by 
the HO endonuclease (Leroy et al, 2003). Ptc2/3 binds to the FHA1 domain of Rad53 and 
dephosphorylates Rad53. Ptc2 binding to FHA1 is dependent on its phosphorylation by 
CK2. 
The endonuclease Sae2 is involved in meiotic and mitotic DSB processing and in subsets 
of recombination pathways together with the MRX complex (Keeney & Kleckner, 1995; 
Rattray et al, 2001; Lobachev et al, 2002; Neale et al, 2002; Clerici et al, 2005) Sae2 
undergoes Mec1- and Tel1- dependent phosphorylation. The sae2Δmec1Δ or sae2Δtel1Δ 
mutants fail to adapt and maintain Rad53 phosphorylation. Overexpression of Sae2 can 
override the checkpoint arrest following UV irradiation in the presence or absence of Tel1 
(Baroni et al, 2004; Clerici et al, 2006). These results suggest that Sae2 may regulate 
Mec1/Tel1 to promote adaptation. 
 
1.5. Rad53  
 
Rad53 is a central protein kinase in the checkpoint pathway in the budding yeast 
S.cerevisiae (Allen et al. 1994). Rad53 is homologous to S.pombe Cds1 and mammalian 
Chk2. Because of its robust hyperphosphorylation after checkpoint activation, modified 
Rad53 is widely used as an experimental marker for checkpoint activation. Rad53 is 
essential for cell viability even in the absence of DNA damage. This lethality of rad53Δ cell 
can be suppressed by over-expressing the largest subunits of ribonucleotide reductase 
(RNR), or by deletion of SML1 encoding a peptide inhibitor of RNR (Zhao et al. 1998), but 
the checkpoint functions cannot be rescued by these manipulations (Desany et al. 1998). 
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The Rad53 protein (821 aa) has a poly-SQ/TQ motif at the N-terminus, two FHA domains, a 
kinase domain and the C-terminal region.  
 
1.5.1 Structure of Rad53 
 
 
 
 
Figure 9. Rad53 and its homologues in different species. The alignment of conserved 
domains: The SQ/TQ-rich domain in maroon, the FHA domain in blue and the kinase 
domain in brown. The highly conserved activation loop is marked by an asterisk.  
 
The SQ/TQ motif 
 
Rad53 contains sixteen SQ/TQ motifs, eight of which are concentrated into two cluster 
domains (SCD1 and SCD2, in which there are four SQ/TQ motifs). These SQ/TQ motifs, 
which are typical consensus sites for PIKKs, are the putative Mec1/Tel1 (ATM/ATR) target 
sites for transducing the DNA damage signal (Traven and Heierhorst, 2005; Kim et al. 
1999). The Rad53-SCD1-4AQ mutant can reduce significantly Rad53 activation in 
response to DNA damage, which can be fully restored by reversion of any single threonine 
residue in this motif (Lee et al. 2003a). SCD1 interacts with the FHA domain of Dun1 and 
also binds the FHA1 domain of Rad53 itself, promoting oligomerization and activation of 
Rad53 (Lee et al, 2003a,b; Harrison 2006). 
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Figure 10. Schematic representation of the domain structure of Rad53: The SQ/TQ-rich 
domain in purple, the FHA domains in green and the kinase domain in blue. 
 
FHA domain (forkhead-associated domain) 
 
Structurally intact FHA domains contain approximately 150 residues (Liao et al. 1999; 
Hammet et al. 2000). Rad53 is a unique kinase containing two FHA domains: an N-terminal 
FHA1 domain and a C-terminal FHA2 domain (Durocher et al. 1999). These two FHA 
domains play a role in recruiting Rad53 to sites of DNA damage for activation (Durocher 
and Jackson, 2002). The two FHA domains are partially redundant for its activation. The 
loss of either FHA domain in presence of DNA damage shortens the normal arrest time. 
The checkpoint defect of the FHA1/FHA2 double mutant is similar to that of the rad53-
kinase dead mutant (Pike et al. 2003; Schwartz et al. 2003).  
In response to DNA damage, Rad53 binds to hyperphosphorylated Rad9, which is 
mediated by both FHA1 and FHA2 domains of Rad53 (Sun et al. 1998; Schwartz et al. 
2002). Mutation of FHA2 reduces Rad53 phosphorylation and the Rad53-Rad9 interaction 
in the presence of MMS, but not HU (Schwartz et al. 2003; Sun et al. 1998). FHA1 binds to 
Rad53 itself, and to Mrc1, the histone chaperone Asf1, the S-phase regulator kinase Dbf4, 
the phosphatase Ptc2, and many other proteins involved in trancription, morphogenesis 
and cytokinesis (Emili et al. 2001; Hu et al. 2001; Duncker et al. 2002; Leroy et al. 2003; 
Schwartz et al. 2003; Sun et al. 1998; Gilbert et al. 2001; Smolka et al. 2006).   
 
Figure 11. The three-dimensional structure of the Rad53 FHA domain consists of a β-
sandwich (Li et al, 2000). One β-sheet has been highlighted in blue, and the other in red. 
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The FHA2 domain (573-730) structure showed the presence of two antiparallel beta-sheets 
making a beta-sandwich. There are 11 β-strands that interact with each other through 
strong hydrophobic interactions and a small C-terminal β-helix. 
Similar to FHA2, the FHA1 domain comprises of a 11-strand β-sandwich with a small C-
terminal helix (Durocher and Jackson, 2002). 
The FHA1 domain of Rad53 recognizes preferentially the peptide pTXXD, and the FHA2 
domain of Rad53 recognizes pTXXL and pYXL (Byeon et al. 2001; Wang et al. 2000). 
However, three-dimensional structures of Rad53-FHA1 bound to the pTXXIY peptide of 
Mdt1, and Ki67-FHA domain binding of the β strand of hNIFK, have shown that FHA 
domains may have more than one type of binding mode (Byeon et al. 2005; Mahajan et al. 
2005). The structure of the Chk2-FHA domain was published in 2002 and was shown to 
recognize the peptide pTXXI (Li et al. 2002; Qin et al. 2003).  
 
Rad53 kinase domain  
 
The structure of the Rad53 kinase domain has not yet been determinated. However, this 
domain contains key functional elements including an activation loop identified by homology 
with other serine/threonine kinases. The phosphorylation of the activation loop at residues 
T354 and T358 is required for Rad53 kinase activity (Fiorani et al, 2008). Other conserved 
residues in the kinase domain such as K227 and D339 are also required for catalytic 
activity. The rad53-K227A single mutant and rad53-K227A+D339A double mutants show 
little or no kinase activity and are checkpoint deficient (Sweeney et al, 2005).  
Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase 
The protein kinase Chk2 (checkpoint kinase 2), the mammalian homolog of the budding 
yeast Rad53, is phosphorylated and activated in response to DNA damage. It consists of 
an N-terminal SQ/TQ cluster domain (SCD), a middle FHA domain, and a C-terminal 
serine/threonine kinase domain (KD) (Ahn et al, 2004). The SCD consists of multiple 
SQ/TQ motifs that contain ATM phosphorylation sites, with Thr68 being the primary site 
that gets phosphorylated in response to DNA damage (Ahn et al, 2000; Matsuoka et al, 
2000; Melchionna et al, 2000). Once phosphorylated, the pThr68 of Chk2 can bind in trans 
to the FHA domain of another molecule promoting dimerization (Ahn et al, 2002, Li 2002). 
The activation of the Chk2 KD requires phosphorylation of Thr383 on the activation loop (T-
loop) (Lee and Chung, 2001; Schwarz et al, 2003). The Chk2 dimer is thought to be 
disassociated into monomers after activation (Ahn et al, 2002). The crystal structure of an 
inactive Chk2 dimer has been recently solved (Cai et al, 2009). The protein Chk2 
crystallizes as a dimer in a SCD-independent manner through FHA-KD and FHA-FHA 
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interactions between two monomers. The FHA-KD interactions are centered on Ile157, a 
residue mutated in the Li-Fraumeni syndrome. Once activated, the kinase domain was 
proposed to change conformation in a way that disrupts either or both the FHA-KD and 
FHA-FHA interfaces, contributing to the dissociation of the dimer.  
 
 
 
Figure 12. Structure of Chk2K249R dimer (Cai et al, 2009). To avoid heterogeneous 
phosphorylation, they used the kinase-dead Chk2 mutant Chk2K249R. The FHA domains and 
the N and C lobes of the bilobal kinase domain are labeled. The yellow spheres indicate the 
approximate positions of the phospho Thr phosphate group. Dotted lines indicate 
disordered regions, including the activation loops. 
 
The C-terminal region 
 
A bipartite nuclear localization signal (NLS) is located in the C-terminal region of Rad53. 
This NLS is required for efficient translocation of Rad53 into the nucleus, where it exerts its 
checkpoint functions as a guardian of the genome. The C-terminal truncation mutant 
perturbs the nuclear localization of Rad53 (Smolka et al. 2006; Sun et al. 1996). The C-
terminal tagging of Rad53 with a 3HA epitope was reported to decrease the levels of Rad53 
in cells, leading to increased sensitivity to HU, but increased resistance to MMS relative to 
the wild type (Cordon-Preciado et al. 2006). Increased resistance of this mutant to MMS 
was correlated with lower levels of Rad53 kinase activity and more rapid recovery from cell 
cycle arrest after transient MMS exposure, but with increased levels of mutagenesis. In our 
study, this C-terminal domain of Rad53 is important for the Asf1-Rad53 interaction. More 
details will be discussed later in this chapter. 
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1.5.2 Rad53 activation model 
 
As discussed above, transducers act to amplify the damage signal that will later activate the 
effector proteins. In response to DNA damage, Rad53 is recruited to Mec1 by Rad9, 
whereas upon replication stress, Mec1 requires Mrc1 for Rad53 activation. 
 
 
Figure 13. Two main pathways for Rad53 activation involving Rad9 and Mrc1. 
 
Mec1 activates Rad53 via Rad9 
 
In response to DNA damage, the RPA-coated ssDNA recruits independently the Mec1-
Ddc2 and the clamp loader complex Rad24-RFC (You et al. 2002; Zou et al. 2003; Lucca et 
al. 2004, Kanoh et al. 2006; Branzei et al. 2009). Once loaded by Rad24-RFC, the PCNA-
like Ddc1-Mec3-Rad17 clamp complex can facilitate Mec1 activation (Majka et al. 2006). 
The mediator Rad9 co-localizes with Mec1 at sites of DNA damage where it is 
phosphorylated by Mec1 (Naiki et al, 2004). Phosphorylated Rad9 recruits Rad53 to the 
damage site where it is then also phosphorylated by Mec1 (Emili 1998; Schwartz et al. 
2002; Sweeney et al. 2005). Mec1-dependent phosphorylation of Rad9 allows Rad9 
dimerization via its C-terminal BRCT-repeats, and facilitates Rad53 autophosphorylation in 
trans, perhaps by increasing the local Rad53 concentration on the Rad9 surface (Soulier 
and Lowndes, 1999; Gilbert et al. 2001; Lisby et al, 2004). After phosphorylation, Rad53 is 
released from Rad9, most likely because the modified protein has a lower affinity for the 
adaptor, and Rad53 then mediates the phosphorylation of its downstream substrates 
(Gilbert et al, 2001). 
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Mec1 activates Rad53 through the mediator Mrc1 in response to replicative stress 
 
Mrc1 is a component of the DNA replisome and travels with the replication forks during 
DNA synthesis (Szyjka et al. 2005; Gambus et al. 2006; Lou et al. 2008; Alcasabas et al. 
2001; Osborn and Elledge. 2003; Tanaka et al. 2001). Mrc1 is the counterpart of Rad9 for 
activating the DNA checkpoints in response to replicative stress (Pellicioli and Foiani, 2005; 
Sweeney et al. 2005; Toh and Lowndes, 2003). Mec1 phosphorylates Mrc1 which is 
required for its binding to Rad53 and for subsequent phosphorylation of Rad53 by Mec1 at 
stalled replication forks (Alcasabas et al. 2001, Chen et al. 2009). 
 
Phosphorylation sites of Rad53 
 
Two studies have characterized by mass spectrometry 32 Rad53 phophorylation sites in 
response to DNA damage induced by 4-NQO (4-nitroquinolineoxide) and MMS (Smolka et 
al. 2005; Sweeney et al. 2005). Thirteen potential autophosphorylation sites and 14 
potential sites phosphorylated by other kinases, such as Mec1 and CDK, were identified in 
response to the UV-mimetic drug 4-NQO by Sweeney et al., whereas Smolka et al. 
identified seven phosphorylated sites in the absence of DNA damage and eight additional 
sites that become phosphorylated in response to MMS. These studies suggest that different 
drugs have different mechanisms to activate Rad53. 
 
 
 
Figure 14. Rad53 phosphorylation sites upon 4-NQO (top) and MMS (bottom) (Pellicio and 
Foiani, 2005). 
 
 
 42 
1.5.3 Rad53 and histone degradation 
 
Rad53 is also involved in the degradation of excess, non-nucleosomal (soluble) histones 
(Gunjan and Verreault, 2003). Rad53 regulates histone protein levels in a kinase-
dependent surveillance mechanism. Consistently, rad53Δ but not mec1Δ mutants are 
extremely sensitive to histone H3 overexpression, and deleting the major H3-H4 gene 
partially suppresses the DNA damage sensitivity, chromosome loss and slow growth 
phenotypes of rad53Δ cells (Gunjan and Verreault, 2003; Singh et al, 2009). These results 
suggest that the housekeeping function of Rad53 is independent of its functions in the DNA 
damage checkpoints. Rad53 maintains cellular histone levels by phosphorylating excess 
non-nucleosomal histones, which are then ubiquitylated and degraded by the proteasome 
(Gunjan and Verreault, 2003; Singh et al, 2009). 
 
1.6 Aim of this thesis 
Asf1 is important for genomic stability since asf1 mutants show indications of increased 
endogenous DNA damage and are sensitive to various genotoxic stresses (Tyler et al, 
1999). Rad53 forms a complex with Asf1 that is dissociated after some types of genotoxic 
stress. The importance of these key proteins in DNA checkpoint and chromatin pathways, 
and the modulation of their interaction in response to genotoxic stress, strongly suggests 
that their interaction plays a role in the response to DNA damage. However, evidence for 
such a role is lacking nearly ten years after the initial description of this complex. The aim of 
this thesis is to contribute to our knowledge of the structural basis for the Asf1-Rad53 
interaction and to determine the functional role of its modulation in response to genotoxic 
stress. 
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Results I  
 
Manuscript submitted for publication: 
 
In this manuscrit, my work contributed to these 3 parts of the results:  
“-Mutations in the H3, H4, and HirA/CAF-1 binding surfaces of Asf1N affect the stability of 
the Asf1-Rad53 complex;  
-Phosphorylation of C-terminal Rad53 serine and threonine residues cannot explain 
dissociation of the Rad53-Asf1 complex upon treatment of yeast cells with hydroxyurea;  
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Abstract  
The histone chaperone Asf1 and the checkpoint kinase Rad53 are found in a complex in budding 
yeast cells in the absence of genotoxic stress. Our data suggest that this complex involves at least 
three interaction sites. One site involves the H3-binding surface of Asf11 with an as yet undefined 
surface of Rad53. A second site is formed by the Rad53-FHA1 domain binding to Asf1-T270 
phosphorylated by casein kinase II. The third site involves the C-terminal 21 amino acids of Rad53 
bound to the conserved Asf1 N-terminal domain. The structure of this site showed that the Rad53 C-
terminus binds Asf1 in a remarkably similar manner to peptides derived from the histone co-
chaperones HirA and CAF-I. Furthermore, C-terminal Rad53-F820 binds the same pocket of Asf1 as 
does histone H4-F100. Thus Rad53 competes with histones H3-H4 and co-chaperones HirA/CAF-I 
for binding to Asf1. Rad53 is phosphorylated and activated upon genotoxic stress. The Asf1-Rad53 
complex dissociated when cells were treated with hydroxyurea but not methyl methane sulfonate, 
suggesting a regulation of the complex as a function of the stress. We identified a rad53 mutation 
that destabilized the Asf1-Rad53 complex and increased the viability of rad9 and rad24 mutants in 
conditions of genotoxic stress, suggesting that complex stability impacts the DNA damage response.  
\body  
Introduction  
Asf1 is a highly conserved chaperone of histones H3 and H4 that has been implicated in histone 
modification and nucleosome assembly/disassembly during DNA transcription, replication, 
recombination, and repair (1). In addition to H3-H4, Asf1 interacts with several other chromatin 
associated proteins in a conserved manner, including the HirA and CAF-I histone co-chaperones (2) 
and the Bdf transcription factors (3). In budding yeast, Asf1 also forms a complex with the DNA 
damage checkpoint kinase Rad53 (4, 5). Curiously, in  mammalian cells, Asf1 does not appear to 
interact with Chk2 (6), the mammalian ortholog of Rad53, but rather with Tousled-like kinases that 
are also implicated in DNA damage responses but that are not conserved in yeast (7). The Asf1-
Rad53 complex was reportedly dissociated when yeast cells were subjected to genotoxic stress in a 
Mec1-dependent manner (4, 5). Mec1 activates Rad53 by phosphorylation in response to genotoxic 
stress. It was suggested that Rad53 could target Asf1 to sites of DNA damage where Rad53 
activating phosphorylation would then liberate Asf1 to facilitate DNA repair (4, 5). This model is 
compelling, but no experimental verification has yet appeared. Rad53 binding to Asf1 was also 
suggested to inhibit the ability of Asf1 to promote transcriptional silencing on the basis of genetic 
data (8). To test the functional importance of the Asf1-Rad53 complex, we mapped the interaction 
surfaces and solved the X-ray structure between the conserved Asf1 N-terminal domain (Asf1N) and 
the C-terminal peptide of Rad53. These structural data allowed us to identify a mutation 
destabilizing the complex. Interestingly, this mutant increased the resistance to genotoxic stress of 
rad9 and rad24 mutants that are partially defective in Rad53 activation.  
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Results  
Rad53 and Asf1 interact through at least two binding sites. We used GST pull-down experiments 
to characterize the Asf1-Rad53 interaction in vitro. Different constructs of Asf1 (full-length and N-
terminal domain) and Rad53 (full-length, and fragments containing the FHA1 domain, the kinase 
domain, the FHA2 domain, or C-terminal peptides) were expressed and purified from E. coli with a 
GST or a 6His tag respectively (Fig. 1A). Full-length Rad53 undergoes extensive 
autophosphorylation when it is expressed in E. coli (9) and this form of the protein was unable to 
bind Asf1 (Fig. 1B). In vitro, dephosphorylation of Rad53 allowed its binding to both GST-Asf1 and 
GST-Asf1N, but not to GST alone (Fig. 1B and Fig. S1A). Thus, Rad53 autophosphorylation blocks 
its binding to Asf1. We further analyzed binding of Rad53 domains to the GST-Asf1 constructs. 
Interestingly, both GST-Asf1 and GST-Asf1N specifically bound C-terminal peptides of Rad53, but 
not the FHA1, kinase, or FHA2 domains (Fig. 1B). Schwartz et al. previously showed that the Rad53 
FHA1 domain could pull down Asf1 in yeast extracts, but treatment of such extracts with protein 
phosphatase prevented binding (10). We confirmed this observation, and we further verified that 
GST-Rad53-Cter peptides (aa 734-821 and 781-821) could pull down Asf1 from yeast extracts 
treated with protein phosphatase (Fig. 1C and Fig. S1B). These results suggest that Rad53 and Asf1 
interact through at least two binding sites: Rad53-FHA1 binds a phosphorylated site of Asf1, and the 
C-terminal peptide of Rad53 binds Asf1N.  
The Rad53 FHA1 domain binds Asf1 phosphorylated on T270. The Rad53 FHA1 domain was 
previously shown to bind pTxxD phospho-threonine peptides (11, 12). We sought Asf1 phospho-
threonines recognized by FHA1. Rad53-FHA1 could pull down full-length Asf1, but not Asf1N 
from yeast extracts, indicating that the phospho-peptide bound by FHA1 is within the acidic C-
terminal tail of Asf1 that contains two pairs of threonines nearby acidic residues (Fig. 1D and S2A). 
We created two mutants in which threonines were changed to alanine in a pairwise fashion 
(T215A+T220A and T265A+T270A) and expressed them in yeast. The Rad53-FHA1 domain could pull-
down the T215A+T220A mutant, but not the T265A+T270A mutant (Fig. 1D). Interestingly, of these 4 
threonine residues, only T270 is conserved in the Asf1 sequence from different yeast species (Fig. 
S2A), and was the only site predicted to bind FHA1 by the STRIP program that we developed for the 
prediction of phospho-binding sites (13). Importantly, phospho-T270 was found on Asf1 that co-
purified with Rad53 from yeast extracts (14). Finally, a synthetic Asf1 peptide phosphorylated solely 
on T270 interacted with the FHA1 domain as determined by NMR chemical shift perturbation 
experiments (Fig. S2B, S2C). The FHA1 binding mode was similar to that of other FHA1 partners 
(see Supplementary results) (11, 12, 15). Isothermal titration calorimetry (ITC) indicated that FHA1 
bound the phospho-T270 peptide with a dissociation constant of 5.3 µM (Fig. S2D). The Rad53-
FHA1 domain was previously shown to interact with peptides that had been phosphorylated by 
casein kinase II (15) whose catalytic subunits are encoded by the yeast CKA1 and CKA2 genes (16). 
We thus examined if this was also the case for Asf1. We found that FHA1 could not pull-down Asf1 
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from a thermosensitive yeast cka1! cka2-ts mutant (16) (Fig. 1D). Furthermore, yeast Cka1 and Cka2 
were found to co-purify with Asf1 in a high-throughput screen (17). Altogether, these results suggest 
that CKA2 phosphorylates at least T270 in Asf1 and that this creates a binding site for the Rad53-
FHA1 domain.  
The Rad53 C-terminal peptide (aa 800-821) binds to Asf1N on the HirA/CAF-I and histone H4 
binding surfaces. We used ITC to define more precisely the minimal Rad53 C-terminal fragment 
sufficient for Asf1N binding. Peptides from 8-40 residues were synthesized and tested for their 
binding affinity to Asf1N (Table 1). The fragment containing the last 21 aa of Rad53 (800-821) was 
the minimum fragment retaining the maximum binding affinity to Asf1N. The dissociation constant 
was 0.08 (±0.03) µM, which is 2 orders of magnitude lower than for the Rad53 FHA1-phospho-Asf1 
interaction (Fig. S3A). We then solved the structure of the complex between Asf1N (1-156) and the 
Rad53 C-terminal peptide (800-821) by X-ray crystallography at 2.9 Å resolution (see Table S1 for 
statistics). The peptide contacts Asf1 in two distinct regions defining two binding epitopes (Fig. 2A). 
The first binding epitope corresponds to Rad53 K804-T811 that lies in an extended conformation on 
the hydrophobic surface of Asf1 between the fourth and the fifth beta strands (residues D58 to F72). 
Three Rad53 residues (K804 CO, A806 NH, and D809 NH, CO), establish backbone pairing hydrogen 
bonds with Asf1 L61 NH, CO and K71 NH, CO respectively. The side chains of two Rad53 residues, 
A806 and L808, point towards the Asf1 conserved hydrophobic surface composed of I60, L61, V62 and 
F72 side chains. In addition, the side chains of two basic residues, K804 and R805 form salt bridges 
with Asf1-D58 and D37 respectively (Fig. 2B). Interestingly, despite a low sequence identity, this 
binding epitope overlaps that of the B domain-like peptides of HirA/p60-CAF-I (2, 18) with a similar 
binding mode (Fig. 2C). Thus, Rad53 binding to Asf1 is competitive with HirA and CAF-I. Based on 
the alignment of HirA, CAF-I and Rad53 C-terminal peptides, we defined an Asf1 binding motif that 
is less stringent than previously proposed (2, 18). We call this motif, (R/K)R(I/A/V)x(L/P), the AIP 
box for Asf1-Interacting Protein box. The motif is centered on one strictly conserved arginine 
residue, corresponding to R805 in the case of Rad53, preceded by a basic residue and followed by a 
hydrophobic residue (I/A/V) in position i+1, and (L/P) in position i+3 with respect to the conserved 
arginine (Fig. S3B). Interestingly, the AIP box is present in a subset of proteins that interact with 
Asf1 in an unknown manner, and may thus potentially bind to the same surface of Asf1 as HirA, 
p60-CAF-I, and Rad53 (Table S2). These proteins include yeast Kap123, Spt15 and human codanin-
1.   
The second Asf1-binding epitope of the Rad53 C-terminal peptide involves its last three residues 
(819-821), and in particular F820 that burrows in the hydrophobic cavity formed by the first and last 
Asf1 beta strands (residues L6, I9 and P144) (Fig. 2B). The position of this aromatic residue overlaps 
that of histone H4-F100 (Fig. 2C), suggesting that this interaction competes with binding of histone 
H4 to Asf1.   
In the crystal structure, the Rad53(800-821) peptide swaps between two Asf1 molecules 
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(Supplementary results and Fig. S4). Analysis of the dynamic behaviour of the complex using NMR 
spectroscopy showed that bridging of Asf1 dimers by the Rad53 peptide is an artefact of the crystal 
packing (Supplementary data and Fig S5). Furthermore, the second epitope is highly dynamic, 
consistent with its ability to swap with a second Asf1 molecule in the crystal.    
We analysed by ITC the relative importance of residues found in contact with Asf1 in the structure 
(Table 1). Consistent with the dynamic analysis, deletion of the second binding epitope or mutation 
of the aromatic F820 residue had a minor impact on the binding affinity, while deletion or mutation of 
hydrophobic or charged residues inside the first epitope (the AIP box) prevented binding or 
dramatically decreased the affinity (Table 1). Thus, the AIP box predominates in Asf1-Rad53 
binding.   
Mutations in the H3, H4, and HirA/CAF-I binding surfaces of Asf1N affect the stability of the 
Asf1-Rad53 complex. We mutagenized Asf1 at a series of residues dispersed over the surface of the 
N-terminal domain (Fig. 3A). Immunoprecipitation of wild-type and mutant Asf1 from yeast cell 
extracts showed that specific residues located in the histone H3, histone H4, and HirA/CAF-I 
binding surfaces of Asf1 were important for its binding to Rad53, whereas other sites had no effect 
(Fig. 3B). The D37R+E39R and the T147A mutants are located in the HirA/CAF-I (2, 18) and histone 
H4 (19, 20) binding surfaces of Asf1 respectively, and both mutants showed reduced affinity for 
Rad53 as predicted by the structure of the Rad53 C-terminal peptide bound to Asf1. Interestingly, 
the V94R mutant that blocks binding to histone H3 (21) is also defective in binding to Rad53. This 
residue is too far from the Rad53 C-terminal peptide to be able to affect its binding directly. 
Furthermore, NMR experiments showed that the V94R mutation has little effect on the overall Asf1N 
tertiary structure (21), so it is unlikely that this mutation affects Rad53 binding through indirect 
conformational changes. We considered two explanations for these results. One possibility was that 
histone H3 bound to Asf1 contributes to the binding of Rad53. To test this possibility, we 
immunoprecipitated Asf1 from yeast cell extracts containing the histone H3-R129E mutant in place of 
the wild type. We previously showed that this mutant is unable to bind Asf1 (22, 23). We found that 
Rad53 was still immunoprecipitated with Asf1 in these extracts in which H3-R129E was not 
associated with Asf1 (Fig. 3C). This result suggests that Rad53 binding to Asf1 does not require 
bridging by histone H3. The second possibility is that Asf1 may directly interact with Rad53 through 
a third binding site overlapping the histone H3 binding surface of Asf1N. Schwartz et al. showed that 
a Rad53-K227A+D339A kinase dead mutant co-immunoprecipitated weakly with Asf1 in yeast 
extracts compared to wild-type Rad53 (10). We confirmed this result and showed that the Rad53-
K227A single mutant was also affected in its interaction with Asf1 (Fig. S6A). These observations 
suggest that the Rad53 kinase domain might be able to interact with Asf1, although we did not 
observe an obvious interaction of the Rad53 kinase domain with GST-Asf1 or GST-Asf1N when all 
proteins were purified from E. coli (Fig. 1B). Alternatively, Rad53 kinase activity may be indirectly 
required for this putative third interaction site. Our current working model is that Asf1 and Rad53 
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interact at 3 three distinct surfaces to form a complex that precludes binding of histones and histone 
co-chaperones to Asf1 (Fig. 3D).  
Phosphorylation of C-terminal Rad53 serine and threonine residues cannot explain 
dissociation of the Rad53-Asf1 complex upon treatment of yeast cells with hydroxyurea. Some 
previous work suggested that Rad53 and Asf1 are found in a complex in yeast cells in the absence of 
genotoxic stress, but the complex was dissociated upon treatment of cells with hydroxyurea (HU) or 
methyl-methane-sulfonate (MMS) (4, 5). We confirmed that Rad53 was no longer 
immunoprecipitated with Asf1 when cells were treated with HU (Fig. 4A, left). However, we found 
that phosphorylated forms of Rad53 still co-immunoprecipitated with Asf1 when cells were treated 
with MMS (Fig. 4A, middle), although the most highly phosphorylated species were not co-
immunoprecipitated. These results are consistent with a mass spectroscopy study showing that Asf1 
remained associated with Rad53 after treating cells with MMS (14). It is possible that earlier work 
showing a dissociation of the complex after MMS treatment of cells used immunoprecipitation 
conditions that were overly stringent. Our results suggest that the complex is differentially regulated 
in response to HU or MMS treatment, presumably to allow a tailored cellular response to these 
distinct genotoxic stresses.  
Rad53 is phosphorylated at more than 20 serine or threonine residues, some of which are 
phosphorylated differentially depending on the type of genotoxic stress (9, 14). Dissociation of the 
Rad53-Asf1 complex may be induced by phosphorylation of Rad53 on specific sites after treatment 
of cells with HU. We noticed that there are three serine/threonine residues in the Rad53 C-terminal 
peptide (T811, S812 and S821) that binds Asf1N. Relative to the Asf1N binding epitopes in the Rad53 
C-terminal sequence (Fig. 2A), T811 and S812 are located at the very end of the first binding epitope, 
and S821 is in the second binding epitope. We mutated each of these serines/threonine to acidic 
residues to produce a phospho-mimetic mutant (Rad53-T811D+S812D+S821E, abbreviated as Rad53-
TSSDEE). If phosphorylation of one or more of these residues is sufficient to induce dissociation of 
the complex in response to HU, we would expect that the phosphomimetic Rad53-TSSDEE mutant 
would not be associated with Asf1 even in the absence of genotoxic stress. However, we found that 
Rad53-TSSDEE co-precipitated with Asf1 in the absence of genotoxic stress, even in the context of 
the non-phosphorylatable Asf1-T265A+270A mutant that is defective in binding Rad53-FHA1 (Fig. 
4A, right). Thus, phosphorylation of C-terminal Rad53 T811, S812 or S821 residues may potentially 
contribute to destabilizing the complex, but is not sufficient to explain dissociation of the complex in 
response to HU treatment.  
The rad53-ALRR mutation destabilizes the Asf1-Rad53 complex and increases the resistance of 
rad9 and rad24 mutants to genotoxic stress. Rad53 A806 and L808 contribute to a hydrophobic 
surface that is important in the binding affinity of the Rad53-C-terminal peptide with Asf1N (Fig. 
2B). Mutation of these residues to arginine greatly decreased the affinity of the Rad53 C-terminal 
peptide for Asf1N (Table 1). Consistently, the yeast Rad53-A808R+L808R (abbreviated Rad53-ALRR) 
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mutant did not co-immunoprecipitate with Asf1 from yeast extracts (Fig. 4B). These observations 
are consistent with a destabilization of the Asf1-Rad53 complex in the rad53-ALRR mutant. In 
contrast, Asf1-T265A+T270A was still bound to Rad53 despite its defective interaction with Rad53-
FHA1 (Fig. 4A, right). Thus, the interaction of the Rad53-C-terminal peptide with Asf1 makes a 
more important contribution to the stability of the complex than does the FHA1 interaction, 
consistent with the ITC data. We tested the rad53-ALRR and asf1-T265A+T270A mutants for 
sensitivity to HU, MMS, and camptothecin, but found no obvious differences with the wild type 
(Fig. 4C and data not shown). Rad53 is activated in response to genotoxic stress by two parallel 
pathways. One pathway is mediated by Mrc1 in response to blocked replication forks (24), and the 
other depends on Rad9, the Rad24 clamp loader complex, and a PCNA-like clamp complex (25). 
Strikingly, we found that Rad53-ALRR increased the resistance of rad9, rad24, and rad9 rad24 
double mutants to MMS (Fig. 4C). It also increased the resistance of the rad9 rad24 double mutant 
to HU. In contrast, Rad53-ALRR did not modify the resistance of the mrc1 mutant to HU or to MMS.   
We compared activating phosphorylation of Rad53 in response to HU and MMS in the wild type, the 
rad53-ALRR mutant, the rad9 rad24 double mutant, and the rad53-ALRR rad9 rad24 triple mutant. 
We found no dramatic differences in Rad53 levels or phosphorylation in any of these contexts, but a 
modest decrease in Rad53 phosphorylation was observed in the rad9 rad24 double mutant, the 
rad53-ALRR mutant, and the rad53-ALRR rad9 rad24 triple mutant compared to the wild type in 
response to HU and MMS (Fig. 4D). This slight difference in phosphorylation was not correlated 
with sensitivity of these strains to HU or MMS exposure. Since defects in Rad53 dephosphorylation 
have also been implicated in sensitivity to genotoxic stress, we compared Rad53 dephosphorylation 
in wild type and rad53-ALRR mutant cells after a transient exposure to MMS, but found no obvious 
difference between the two strains (Fig. S6B). Thus, the ability of the Rad53-ALRR mutant to 
increase the resistance of rad9 and rad24 mutants to genotoxic stress does not appear to be due to 
obvious differences in Rad53 activation or inactivation.  
  
Discussion  
We discovered a remarkable complexity to the Asf1-Rad53 interaction that appears to involve three 
distinct interaction surfaces. First, we show that the Rad53-FHA1 domain binds Asf1 phosphorylated 
at T270 in its C-terminal acidic tail domain in a casein kinase II-dependent manner. Rad53-FHA1 
binds multiple phospho-proteins (13), so there is likely to be dynamic competitive interactions that 
contribute to the functions of Rad53 in DNA replication and repair. The affinity of the pT270 Asf1 
phosphopeptide is modest (5µM) compared to other known FHA1 partners like Ptc2 and Cdc45 
(~0.5 µM) (13). Mutation of Asf1-T265 and T270 to alanine prevented binding of Asf1 to Rad53-
FHA1, but this mutant had no apparent phenotype and still co-immunoprecipitated with Rad53. We 
defined a second interaction surface comprised of the C-terminal 21 aa of Rad53 that binds the same 
surfaces of the conserved Asf1 N-terminal domain as do the histone co-chaperones HirA/CAF-I and 
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histone H4. Indeed, the Rad53 C-terminal peptide has a strikingly similar binding mode to the HirA 
and p60-CAF-I B-domain peptides (2, 18), and it is clear that the three proteins must compete for 
binding to the same surface of Asf1N. Considering the relative affinity of the corresponding peptides 
for Asf1, the S. cerevisiae Rad53 C-terminal peptide presents the highest affinity (~100 nM, Table 1) 
compared to the FHA1 binding site and also compared to that of human and S. pombe HirA/p60-
CAF-I B-domain peptides for Asf1 (~2 µM) (2, 18). Based on the structure of Rad53, HirA, and 
p60-CAF-I B-domain peptides in complex with Asf1, we derived a new minimal sequence motif 
(R/K)R(I/A/V)x(L/P) that we call the AIP box (Asf1-Interacting Protein box), for peptides 
potentially able to bind this same surface of Asf1 (Fig. S3B). In the three founding members of the 
AIP box family, namely Rad53, HirA and p60-CAF-I, mutation of the central arginine residue or the 
two hydrophobic residues in positions i+1 and i+3 abolishes the binding of the peptide to Asf1 
(Table 1) (2, 18). This small degenerate binding motif could be compared to the well-characterized 
PCNA PIP box that is found in many proteins associated with the replication fork with binding 
affinities to PNCA in the same range as the AIP-box to Asf1 (100 nM to 50µM) (26). The AIP-box 
is too degenerate to identify novel Asf1 binding partners by searching in the large database of non-
redundant protein sequences. However, we found this motif in a subset of proteins that bind Asf1 in 
an unknown manner (Table S2). It is now possible to mutate these potential AIP boxes to assess their 
functional importance. Interestingly, the Rad53 AIP box is conserved only in yeast species, 
consistent with the fact that the human Chk2 ortholog was not found in a complex with Asf1 (6).   
Phe-820 of Rad53 also competes with Phe-100 of histone H4 for binding to a distinct surface of 
Asf1N. It is unlikely that the Rad53 C-terminal peptide is able to compete with binding of the 
heterodimeric H3-H4 to Asf1N that occupies a much greater surface than that of the F820 binding 
pocket. However, the Asf1-V94R mutant is defective in both histone H3 and Rad53 binding. Since 
Asf1-V94 is distal to the surface bound by the Rad53 C-terminus, an additional region of Rad53 
likely interacts with the H3 binding epitope on Asf1N. Similarly, it was suggested that in addition to 
its AIP box, other regions of HirA must contribute to its interaction with Asf1 and impart a 
specificity for binding to the mammalian Asf1a isoform (2).    
Rad53 and Asf1 are found in a complex in yeast cells in the absence of genotoxic stress. Our data 
indicate that Rad53 competes with histones H3-H4 and the co-chaperones HirA and CAF-I for 
binding to Asf1. We found that the Asf1-Rad53 complex was dissociated when cells were treated 
with hydroxyurea, a ribonucleotide reductase inhibitor, but not when cells were treated with the 
methylating agent MMS. Rad53 is activated by phosphorylation at multiple sites in response to 
genotoxic stress. Some sites, such as a T-loop phosphorylation, are probably necessary for Rad53 
activation in all situations. However, other phosphorylations are specific to cells treated with the 
UV-mimetic 4-nitro-quinoline 1-oxide or with MMS (9, 14). Some phosphorylation sites specific to 
HU treatment may explain the dissociation of the Asf1-Rad53 complex in this condition relative to 
MMS. A phospho-mimetic mutant at putative phosphorylation sites in the C-terminus of Rad53 did 
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not lead to dissociation of Asf1. Thus, we suggest that phosphorylation within the putative third 
interaction surface in the Asf1-Rad53 complex is required for dissociation of the complex in 
presence of HU. Dissociation of the Asf1-Rad53 complex would increase the pool of Asf1 
competent for binding histones and other partners, and could also modify the ability of Rad53 to 
phosphorylate specific substrates. The identification of Rad53 phosphorylation sites that are specific 
to HU-treated cells would allow further testing of this model.   
Our structure of Asf1N in association with the Rad53 C-terminal peptide allowed us to identify 
residues important for the stability of the complex. The rad53-ALRR mutation disrupts an important 
hydrophobic contact and destabilizes the Asf1-Rad53 complex in yeast cells. Although this mutant 
did not have an obvious phenotype on its own, we found that it increased the resistance to genotoxic 
stress of rad9 and rad24 mutants. Rad9 and Rad24 are implicated in activation of Rad53 in response 
to DNA double-strand breaks (25). In asynchronously growing cells, we observed only modest 
decreases in Rad53 phosphorylation in the rad9 rad24 mutant treated with HU or MMS compared to 
wild type cells, presumably because Rad53 is still efficiently activated by Mrc1 at stalled replication 
forks in these cells (24). The rad53-ALRR mutation did not significantly modify the profile of Rad53 
phosphorylation, so the increased viability of rad53-ALRR rad9 rad24 mutants exposed to MMS or 
HU may not be through effects on Rad53 activity. We favor the hypothesis that the decreased 
stability of the Rad53-Asf1 interaction in the rad53-ALRR mutant increases cell viability through 
increased tolerance or repair of lesions (including reconstitution of chromatin structure) provoked by 
HU or MMS in the rad9 rad24 mutants. This could presumably occur by the increased availability of 
Rad53 or Asf1 to interact with its multiple alternative partners at the levels of DNA metabolism and 
chromatin.  
  
Materials and Methods  
Detailed information is provided in the Supplementary Methods.  
Data deposition: The atomic coordinates and structure factors have been deposited in the Protein 
Data Bank in Europe (PDBe), www.ebi.ac.uk/pdbe (PDB ID code ###).  
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Figure Legends  
Fig. 1. Rad53 and Asf1 interact through at least two binding sites. (A) Schematic representation 
of the different constructs of Asf1 and Rad53 produced in E. coli for pull-down assays. (B) GST 
pull-down assays with GST, GST-Asf1, GST-Asf1N and different 6His-tagged fragments of Rad53. 
The asterisk indicated a dimeric form of GST and the double asterisk indicates a GST-Asf1 
degradation product. (C) GST-pull-down assays with GST, GST-FHA1, GST-Rad53-C-ter, and 
yeast extracts expressing Asf1-myc. The asterisk corresponds to a degradation product of GST-C-ter. 
(D) GST pull-down assay with GST (control) and GST-FHA1 (Pull-down) of yeast extracts 
expressing Asf1-myc full length, Asf1N-myc, or Asf1-myc mutated on threonine residues of the C-
terminal tail as indicated. The pull-down was performed with extracts from the wild-type or cka1! 
cka2-ts (thermosensitive mutant of CKA2) mutants expressing or not WT CKA2 from a plasmid, and 
with the addition of calf intestinal phosphatase to cell extracts where indicated (CKA2 + CIP).     
Fig. 2. Crystal structure of Asf1N in complex with the C-terminus of Rad53(800-821). (A) 
Cartoon representation of Asf1 (in grey) bound to Rad53(800-821) in orange. Dashed lines are used 
to materialize the peptide chain between the two binding epitopes. Important Rad53 residues are 
labeled. (B) Detail of the interface delineated in panel A. In the crystal structure, the peptide bridges 
epitopes on two different Asf1 molecules, but NMR solution analyses indicate that the peptide 
normally binds a single Asf1 molecule (see Sup. Data and Fig. S4). Hydrophobic side chains are 
shown as spheres, polar and charged residues as sticks. Polar contacts are shown as yellow dashed 
lines. Residue labels are indicated. (C) Cartoon representation of Asf1 (in grey) bound to the HirA B 
domain (in green) and to the H3 (in rose)-H4 (in magenta) complex. Residues overlapping with 
Rad53 are indicated.  
Fig. 3. Putative third interaction surface involving the H3-binding surface of Asf1 and the 
kinase domain of Rad53. (A) Cartoon representation of Asf1 (in grey) bound to the Rad53-K804-
S812 peptide (in orange) and to the H3 (in rose)-H4 (in magenta) complex. Residues that were 
mutated to test their effect on Rad53 binding are shown with spherical atoms for N (blue), O (red), 
and C (grey). (B) Co-immunoprecipitation of Rad53 and histone H3 with the indicated mutants of 
Asf1-myc. Input indicates proteins in total cell extracts. IP indicates proteins co-precipitating with 
Asf1-myc on anti-myc beads. Asf1 is tagged with a 13-myc epitope, except for the A128D-K129D and 
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R123E mutants that have fewer repetitions of the myc epitope. (C) Rad53 co-precipitates with Asf1 in 
extracts from a histone H3-R129E (hht2-R129E) mutant that cannot bind Asf1. (D) Schema of 
tripartite model for the Asf1-Rad53 interaction. The question mark indicates that the putative 
interface between Asf1N and  
the kinase domain of Rad53 awaits further experimental verification.  
Fig. 4. Dissociation of the Asf1-Rad53 complex when cells are treated with HU but not MMS, 
and destabilization of the complex by the rad53-ALRR mutation and its phenotypic 
consequences. (A) Asf1-myc was immunoprecipitated from extracts of control cells and cells treated 
with 200 mM HU for 2 h at 30°C (left panel) or with increasing MMS (0.05%, 0.1%, 0.15%, 0.2% 
final concentration) for 1 h at 30°C (middle panel). Right panel: Wild-type Rad53 and the Rad53-
TSSDEE (T811D+S812E+S821E) mutant co-precipitate with the Asf1-T265A+T270A-myc non-
phosphorylatable mutant that is defective in binding Rad53-FHA1. (B) Rad53-ALRR (A806R+L806R) 
does not co-immunoprecipitate with Asf1-myc in conditions allowing efficient co-
immunoprecipitation of wild-type Rad53. (C) rad53-ALRR increases the growth of rad9 and rad24 
mutants in the presence of MMS or HU. (D) Only minor differences in Rad53 phosphorylation in 
W303 wild type, rad9 rad24, rad53-ALRR, and rad53-ALRR rad9 rad24 yeast strains during normal 
growth or after treatment with 200 mM HU for 2 h at 30°C or with 0.05% MMS for 1 h at 30°C.   
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Table Legends  
  
Table 1. Summary of ITC data for Asf1N binding to C-terminal fragments of Rad53  
 
  
Supplementary Results 
NMR Characterization of the complex of Rad53 FHA1 (1-164) with Asf1 (266-277)  
No chemical shift variation of the FHA1 1H-15N heteronuclear single-quantum coherence spectrum 
(HSQC) amide resonances was observed upon addition of the unphosphorylated Asf1 peptide 
266DIESTPKDAARS277 (Sup. Fig S2B). In contrast, a few FHA1 amide resonances shifted upon the 
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addition of the phosphorylated Asf1 peptide (pT(Asf1) 266DIES(pT)PKDAARS277 )(Sup. Fig S2C). 
The 1H-15N HSQC of the free FHA1 domain was nearly identical to the one published (1), thus 
allowing the assignment of at least five signals corresponding to R35/NHe, R70/NHe, N86, S85, and 
G133. The chemical shift variations observed after addition of pT(Asf1) were virtually identical in 
magnitude and direction to those observed for pT(Rad9) (1) or pT(Ptc2) (2). In particular, S85, N86, 
and the side chain proton of R70 (involved in the binding of the phosphate group of the phospho-
threonine) showed large chemical shift variations, whereas the signal corresponding to NH$ of R35 
remained unchanged. These data indicated a similar binding mode for pT(Asf1), pT(Ptc2) and 
pT(Rad9).  
  
Dynamic analysis of the Rad53 C-terminal peptide (800-821) bound to Asf1N by NMR  
In the crystal structure, two Rad53(800-821) peptides were found swapped between two Asf1 
molecules (Sup. Fig. S4). We thus asked if the peptide could promote Asf1 dimerization in solution 
by analyzing the same complex using NMR spectroscopy. The Asf1 amide chemical shift changes 
upon Rad53(800-821) binding showed that, in solution, the regions of Asf1 perturbed by the peptide 
are those predicted by the crystal structure of the complex, confirming that the binding mode is 
similar in solution (Sup. Fig. 5A). In addition, we recorded and assigned some intermolecular 
nuclear Overhauser effects (NOEs) that were fully compatible with the X-ray structure (data not 
shown). 15N-1H heteronuclear relaxation parameters (R1, R2 and NOEs) of uniformly 15N labeled 
Asf1N allowed the calculation of the global correlation time of free and bound Asf1 (Sup. Fig. 5B). 
These were fully compatible with the formation of a heterodimeric Asf1-Rad53 complex (Sup. Fig. 
4C). We thus conclude that the swapping of Rad53 (800-821) observed in the crystal structure is an 
artefact of crystal packing and that the peptide wraps around one Asf1 molecule (Fig. 2A, Sup. Fig. 
S4B). We were unable to define by NMR spectroscopy the precise conformation of the linker 
between the two epitopes because of the lack of intermolecular NOE and short range NOE (data not 
shown). We thus analyzed the dynamic behaviour of the uniformly 15N labelled free and bound 
Rad53(800-821) peptide (Sup Fig. 5C). 1H-15N heteronuclear relaxation parameters together with the 
HN chemical shifts clearly show that the free Rad53 peptide is unfolded and folds upon Asf1 
binding. Values of R1, R2 and 15N-1H heteronuclear NOEs of the bound peptide are compatible with 
a tight Asf1 binding with a significant exchange contribution (see Lipari Szabo analysis Sup. Fig. 
5D). Fluctuating ends corresponding to residues 800-805 and 819-821 are observed, even though the 
819-821 segment corresponds to the second Asf1 binding epitope. This epitope is thus highly 
dynamic, consistent with its ability to swap with a second Asf1 molecule in the crystal packing.    
  
  
Supplementary Materials and Methods 
 
Protein expression and Purification for crystallization experiments. 
Production and purification of recombinant proteins for structural studies, isothermal calorimetry 
(ITC) and pull-down experiments was performed with the same procedure. Uniformly 15N and 15N-
13C labelled Asf1(1-156) and Rad53(800-821) was also performed with the same protocol, except 
that the cellular culture was performed in minimal mediu(M9) supplemented with 15N ammonium 
chloride and/or 13C glucose. Recombinant soluble (His)6-tagged GST fusion proteins expressed from 
pETM30 (gift from G. Stier, EMBL Heidelberg) constructs were immobilized on GSH agarose 
(Sigma) and then eluted with an excess of glutathione (Sigma). They were cleaved using a (His)6-
tagged TEV protease (1% w/w of protease / fusion protein). A Ni-NTA agarose column (Qiagen) 
was used to trap the (His)6-tagged TEV protease and the (His)6-tagged GST as described (3). For 
structural biology and ITC experiments, an additional final purification step using either ion 
exchange chromatography (resource Q, GE Healthcare) or reverse phase chromatography (proRPC 
16/10, GE Healthcare) was performed for Asf1 and the Rad53 peptides respectively, as decribed (4, 
5)). Unlabeled Rad53 peptides used for ITC, NMR or crystallization trials were obtained by 
chemical synthesis (Genecust). The peptide and protein concentrations were precisely measured by 
amino acid analysis. 
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Crystallization and Data Collection   
Purified Asf1 (1-156) was concentrated to 9 mg/mL in a 3 kDa limit concentrator (Millipore) and 
buffer exchanged to 50 mM Tris 50-pH 7.4. The protein was incubated 1 hour at room temperature 
with a 1x Protease inhibitor cocktail (Roche). The peptide was solubilized in water, the pH was 
adjusted to ~7.4, lyophilized and resuspended in water to the final concentration of 10 mg/ml. 
Concentrated peptide was added to the protein at a final ratio of one Asf1 molecule for three Rad53 
peptide molecules. Crystals of the complex were grown by sitting drop vapour diffusion at 20°C 
against reservoir solution containing 35% PEG 4000, 0.1M Na Acetate-pH 4.6, 0.2 M NH4 sulphate. 
Crystals were grown for several days and reached sizes of 100!m x 40!m x 40!m. Crystals were then 
flash-frozen in liquid nitrogen after cryo-protection with glycerol supplemented reservoir solution.  
Diffraction data were collected on the Proxima1 beamline at the SOLEIL synchrotron (Gif-sur-
Yvette, France). Crystals belonged to space-group C121 and diffracted up to 2.94Å resolution (see 
Sup. Table 1). All data were processed and integrated using XDS (Sup. Table S1) (6).  
 
X-ray Structure Determination and Refinement   
Structure resolution was carried out using molecular replacement using the structure of yeast Asf1 as 
search model (pdb code 1ROC). Four proteins per asymmetric unit were found. The structure was 
refined and the peptide model was built using the software Buster with non crystallographic 
symmetry constrains and TLS (Sup. Table S1) (7) and visualized with the software Coot (8). 
Structure representations presented in the paper were drawn with Pymol 
(http://pymol.sourceforge.net/).   
  
NMR characterization of the complex of Asf1 (1-156) with Rad53 (800-821)  
NMR samples were prepared in the following buffer: Tris D11 10 mM, pH 7.4, NaN3 0.1%, EDTA 1 
mM, DSS 0.1 mM. D2O 10% or 100%. Several samples were used in this study: uniformly 15N (or 
15N/13C) labeled yeast Asf1 (1-156) alone or in complex with unlabeled Rad53 (800-821), uniformly 
15N (or 15N/13C) labeled Rad53 (800-821) in complex with unlabeled Asf1 (1-156). For these 
samples, the concentrations of the labeled and unlabeled molecules were 0.1 mM and 0.2 mM 
respectively. NMR experiments were carried out on Bruker DRX-600 MHz and 700 MHz 
spectrometers equipped with cryoprobes at 278°K or 303°K. 1H, 15N and 13C backbone resonance 
assignments of free and Rad53(800-821) bound Asf1 were achieved using standard 15N-1H – HSQC, 
15N-edited NOESYHSQC (mixing time of 120 ms), HNCA, HN(CO)CA, CBCA(CO)NH, HNCO, 
HBHA(CO)NH, CBCACOHA and HNHA experiments. Side chain assignments were achieved 
using HCCH-TOCSY (mixing time of 10 ms), HCCH-COSY, and 13C edited NOESY-HSQC 
experiments (mixing time of 120 ms). Proton chemical shifts (in ppm) were referenced relative to 
internal DSS and 15N and 13C references were set indirectly relative to DSS using frequency ratios (9). 
All NMR data were processed using Xwinnmr (Bruker) and analyzed using Sparky (T. D. Goddard 
and D. G. Kneller, University of California, San Francisco). Intermolecular NOEs were obtained by 
filtered edited experiments described in (10) (mixing time of 150 ms). They are fully compatible 
with the contacts observed in the crystal structure. Cumulative chemical shift variation of Asf1 
amides upon Rad53(800-821) addition was calculated as ∆ = [(HNb-HNf)2 + (2.75(Hb-Hf))2 + 
(0.17(Nb-Nf))2]1/2, where b and f refer to the bound and free form respectively. The scaling factors 
normalize the magnitude of the 1HN, 1H and 15N chemical shift changes (in ppm unit) (11). 15N-1H 
heteronuclear relaxation data R1, R2 and 15N-1H heteronuclear NOEs of free and bound Asf1, and free 
and bound peptide were measured at 700 Mhz with the standard Bruker pulse scheme in an 
interleaved 3D experiment using a recycle delay of 4 s. R1 values were calculated from fits of 12 
relaxation delays of 1, 1, 20, 50, 100, 200, 350, 500, 800, 1000 and 1500 ms. R2 values were 
calculated from fits of 11 relaxation delays of 16, 16, 32, 49, 65, 81, 98, 130, 228 and 326 ms. Data 
were analysed with a macro of the Sparky software (T. D. Goddard and D. G. Kneller, SPARKY 3, 
University of California, San Francisco). The Lipari and Szabo analysis was performed with the in 
house Matlab macro as described (12).    
  
NMR Characterization of the complex of Rad53 FHA1 (1-164) with Asf1 (266-277)  
NMR sample was prepared in the following buffer: phosphate 10 mM, pH 6.5, DTT 1 mM, NaN3 
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0.1%, EDTA 1 mM, DSS 0.1 mM. D2O 10%. The concentration of uniformly 15N labeled FHA1 
domain was 163 M. Phosphorylated or unphophorylated 266DIES(pT)PKDAARS277 peptide derived 
from Asf1 sequence pT(Asf1), obtained by chemical synthesis (Genecust), was progressively added 
with a molar ratio at the end of the titration of 1:3.4. NMR experiments were carried out on a Bruker 
Advance-700 spectrometer equipped with a cryoprobe at 293°K. Experimental conditions were 
identical to those used for the structure determination by NMR spectroscopy of FHA1 in complex 
with a tight binding peptide from Rad9 in (1, 2).  
 
Isothermal Titration Calorimetry (ITC) experiments.  
ITC experiments were performed using a MicroCal VP-ITC instrument (GE Healthcare) at 5°C for 
the interaction with the C-terminal peptides of Rad53 and 303°K for the interaction of FHA1 with 
the phosphorylated Asf1 peptide. A 15 µM solution of the FHA1 or Asf1(1-156) domains in buffer 
Tris 50 mM, pH 8 and Tris 50mM, pH 7.4 respectively was introduced in the calorimeter cell (1.337 
mL) and was titrated by a 200 µM and 250µM respectively solution of Asf1 or Rad53 C-terminal 
peptides respectively using automatic injections of 6µL. Integration of the peaks corresponding to 
each injection and correction for the baseline were done using Origin-based software provided by the 
manufacturer. Fitting of the data to an interaction model results in the stoichiometry (N), equilibrium 
binding constant (Ka) and enthalpy of complex formation (∆H). The experimental data allow 
calculation of the free energy change (∆G) and of the entropy term (T∆S) according to the classical 
thermodynamic formulae: ∆G = -RT×ln Ka; ∆G = ∆H - T∆S, where R is the universal gas constant 
and T is the absolute temperature. All experiments were repeated twice with similar results.   
 
GST pull-down assays.  
40 g of purified (His)6-GST-fusion proteins were immobilized on GSH agarose and equilibrated 
with 200 l of buffer H150 (20 mM Hepes-NaOH, pH 7.4, 150 mM NaCl, 0.5% NP40, 1 mM 
EDTA, 1mM DTT). E. coli (1 mg) or S. cerevisiae (1 mg) cellular extracts solubilized in the same 
buffer were added to beads. Beads were washed successively with buffers identical to buffer H150 
with increasing NaCl concentration up to 300mM. The beads were collected by centrifugation, 
washed twice in 20 mM Hepes and two times in 20 mM Hepes, 50mM NaCl, 0.5% NP40. Bound 
proteins were analyzed by SDS-PAGE and revealed by a polyclonal antibody against the (His)6 tag 
(Santa Cruz Biotech 8036-HRP) or by polyclonal antibody against the myc tag (Santa Cruz Biotech 
9E10). Bound (His)6-tagged GST fusion proteins were also revealed by a polyclonal antibody 
against the (His)6 tag.   
  
Construction of mutants.   
A 3.5 kb genomic EcoRI fragment containing the RAD53 gene and flanking sequences was 
transferred from Yeplac195-RAD53 (13) to the pRS306 Integrating-URA3 vector (14). This plasmid 
was then used as template for mutagenesis using the Stratagene QuikChange kit. pRS-rad53-ALRR 
was linearized within the RAD53 promoter sequence by digestion with PacI to target integration of 
the plasmid at the rad53!::HIS3 locus of CMY1227. Transformants were then screened for loss of 
the pBAD70 (2µ-TRP1) plasmid. Construction of Asf1 mutants was described previously (5), as was 
the construction of the hht2-R129E mutant (4).   
  
Yeast strains.   
All strains were in the W303 background, except for CMY1389 and CMY1520 in the S288C 
background and CMY1357 and 1360 in the YPH250 background.  
  
W303-1a  MATa ade2-1 his3-11,15 leu2-3, 112 trp1-1 ura3-1  
CMY1139 W303-1a rad53::HIS3  sml1-1  
CMY1155  W303-1a rad24::URA3  
CMY1156  W303-1a rad9::HIS3 rad24::URA3  
CMY1158 W303-1a rad9::HIS3  
CMY1227  W303-1a rad53::HIS3/pBAD70 (2µ,TRP1)-RNR1  Ref. (15)  
CMY1396 W303-1a ASF1-3HA-kanMX6 bar1::LEU2 his3-11 leu2-3,112  lys2 trp1-1 ura3-1  
CMY1501 SEY1127 W303-1a mrc1!-3::his5+ Ref. (16)   
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CMY1558   W303-1a rad53-TSSDEE::URA3::rad53!::HIS3  
CMY1561 W303-1a rad53-K227A::kanMX  
CMY1562   W303-1a rad53-ALRR::URA3::rad53!::HIS3  
CMY1563 W303-1a RAD53::URA3::rad53!::HIS3  
CMY1564   W303-1b rad53-ALRR::URA3::rad53!::HIS3  
CMY1565 W303-1 rad53-ALRR::URA3::rad53!::HIS3 mrc1!-3::his5+  
CMY1566   W303-1a rad53-ALRR::URA3::rad53!::HIS3 rad24::kanMX  
CMY1567   W303-1a rad53-ALRR::URA3::rad53!::HIS3 rad9::LEU2  
CMY1568   W303-1a rad53-ALRR::URA3::rad53!::HIS3 rad24::kanMX rad9::LEU2  
CMY1569   W303-1a rad9::LEU2  
CMY1570   W303-1a rad24::kanMX   
CMY1571  W303-1a rad24::kanMX rad9::LEU2  
CMY1364  W303-1b asf1!::kanMX  
CMY1389  FY2162 MATa his3"200 leu2"1 ura3-52 trp1"63 lys2-128# Ty912.35-lacZ::his4   
             (hht1-hhf1)"::LEU2 (hht2-hhf2)"::HIS3/pDM9=pRS416(CEN URA3)-  
             HHT1+HHF1  Ref. (17)  
CMY1520  MATa his3"200 leu2"1 ura3-52  trp1"63  lys2-128#  Ty912.35-lacZ::his4  (hht1-  
                         hhf1)"::LEU2  (hht2-hhf2)"::HIS3/ pDM18 (CEN TRP1)-hht2-R129E+HHF2  
CMY1357  YDH6 ade2–101 his3-200 leu2-1 lys2–801 trp1-1 ura3–52 cka1-1::HIS3 cka2-  
                          1::TRP1/ pCEN6-LEU2-CKA2  Ref. (18)  
CMY1360 YDH13 ade2–101 his3-200 leu2-1 lys2–801 trp1-1 ura3–52 cka1-1::HIS3  
                          cka2-1::TRP1/ pCEN6-LEU2-cka2-13ts  Ref. (18)  
  
  
 Co-immunoprecipitation experiments.   
Figure 3B: W303-1a transformed by plasmids pRS314 (CEN-TRP1) containing ASF1-myc, or asf1-
V94R-myc, or asf1-T147A-myc, or asf1-D37R+E39R-myc, or asf1-V90R-myc, or asf1-E124R+N125R-myc, 
or asf1-A128D+K129D-myc, or asf1-R123E-myc  were grown in synthetic medium containing 
casamino acids, adenine, and uracil in order to maintain selection for plasmid pRS314, and harvested 
at an O.D. 600nm of 0.8. Cells were resuspended in 4 ml extraction buffer (50mM Tris pH 7.5, 100 
mM NaCl, 10% glycerol, Roche protease inhibitor cocktail w/o EDTA) and broken in an Eaton 
press. Extracts were transferred to 50 Ti tubes and centrifuged (40 krpm, 1h, 4°C), and the protein 
concentration in the supernatant was determined with the Bradford reagent (Bio-Rad). Extracts (5 to 
10 mg of protein for anti-myc IP in a final volume of 1 ml) were incubated with anti-myc beads that 
had been washed with extraction buffer on a rotating wheel O/N at 4°C. The beads were washed two 
times with 1 ml extraction buffer + 0.1% Tween-20 and immunoprecipitated proteins were 
solubilized by heating in the presence of sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) sample buffer. Total cell extracts (40 µg) and immunoprecipitated proteins were 
seperated by SDS-PAGE, transferred to nitrocellulose membranes, incubated with goat anti-Rad53 
yC-19 (Santa Cruz Biotechnology sc-6749) or mouse monoclonal 9E10 (anti-myc) antibodies 
followed by anti-goat or anti-mouse secondary antibodies. Proteins were detected using a Li-Cor 
Odyssey Imager.  
Fig. 3C: CMY1389, CMY1389/pRS314-ASF1-myc and CMY1520/pRS316-ASF1-myc were grown 
in synthetic medium selecting for plasmids. Protein extracts and immunoprecipitates were prepared 
as described above. Membranes were incubated with rabbit anti-H3 antibody (Abcam ab-1791) 
followed by anti-rabbit secondary antibody.  
Fig. 4A and Fig. S8: left and middle panels: W303-1a/pRS314-ASF1-myc was grown in 250 ml 
synthetic medium containing casamino acids, adenine, and uracil till an OD600 of 0.8. Cells were 
then incubated with MMS (0.05%, 0.1%, 0.15%, 0.2% final concentration) for 1h or 200 mM HU for 
2h. Protein extracts and immunoprecipitates were prepared as described above.  
Fig. 4A-right: CMY1227/pRS316-asf1-T265/270A-myc, W303-1a/pRS314- asf1-T265/270A-myc, 
CMY1558/ pRS314- asf1-T265/270A -myc were grown in synthetic medium selecting for plasmids 
where necessary, and protein extracts and immunoprecipitates were prepared as described above.  
Fig. 4B: W303-1a, W303-1a/pRS314-ASF1-myc, CMY1562/pRS314-ASF1-myc and 
CMY1227/pRS314-ASF1-myc were grown in 250 ml medium selecting for plasmids where 
necessary, and protein extracts and immunoprecipitates were prepared as described above.  
Fig. S6A: W303-1a, W303-1a/pRS316-ASF1-myc, CMY1139 rad53Δ/pRS316-ASF1-myc, 
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CMY1561 rad53-K227A/pRS314-ASF1-myc, CMY1139 rad53Δ/pRS314-ASF1-myc+pRS316-
rad53-K227A+D339A, CMY1227/pRS314-ASF1-myc were grown in synthetic medium selecting for 
plasmids where necessary, and protein extracts and immunoprecipitates were prepared as described 
above.  
  
Analysis of Rad53 Phosphorylation.   
W303-1a, CMY1156, CMY1562, and CMY1568 were grown in YPD to an OD600 of 0.8. Cells 
were then incubated with MMS (0.05% final concentration) for 1h or with 200 mM HU for 2h. Yeast 
extracts were prepared by glass bead beating in 20% trichloroacetic acid (TCA), washing the glass 
beads in 5% TCA, and combining the wash with the lysate. The protein suspension was then 
pelleted, resuspended in 1x Laemmli loading buffer (pH8.8), boiled for 5 min, pelleted and the 
supernatant was retained as a whole-cell extract. Excess acid was neutralized with Tris buffer 
(pH8.8) when necessary. Protein extracts were resolved on 8% SDS-PAGE gels, and Rad53 was 
detected with an anti-Rad53 rabbit polyclonal antibody at 1 :10000 dilution. This antibody was 
initially generously provided by John Diffley (Cancer UK). We later obtained additional antiserum 
by immunizing rabbits with Rad53-6His protein purified from E. coli.  
  
Analysis of Rad53 Dephosphorylation.   
W303-1a and CMY1562 were grown in YPD. Cells were treated with %-factor (30µM final) for 2h 
at 30°C and then with 0.005% MMS for 30 min at 30°C. Pellets were washed two times with YPD 
and then released into fresh YPD. Cells were harvested at 0’, 30’, 60’, 120’ after release. Protein 
extracts were prepared by TCA precipitation as described above.  
  
Phenotypic analysis.   
For spotting analyses, cells were resuspended at 107/ml, subjected to 10-fold serial dilutions and 3µl 
of each dilution was spotted on plates of YPD, YPD + 100 mM HU, and YPD + 0.0025% MMS. 
Growth was assayed at 72h.   
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Results II 
 
3. Results not yet submitted for publication 
 
3.1 Mutation of possible phosphorylation sites at the Rad53 C-terminus 
 
In the absence of genotoxic stress, Asf1 forms a stable complex with Rad53. In our 
submitted article, we showed that the Asf1-Rad53 complex was dissociated when cells 
were treated with HU, but not MMS. This dissociation of the complex upon HU treatment 
may be induced by phosphorylation of Rad53 on specific sites. Rad53 has more than 20 
serine or threonine residues that are potential phosphorylation sites, some of which are 
phosphorylated differentially depending on the type of genotoxic stress. We noticed that 
there are three serine/threonine residues in the Rad53 C-terminal peptide (T811, S812 and 
S821) that binds Asf1N. We mutated each of these to acidic residues or to alanine to 
produce a phosphomimetic or a non-phosphorylatable mutant. If phosphorylation of one or 
more of these residues was sufficient to induce dissociation of the complex in response to 
HU, we would expect that the phosphomimetic Rad53-TSSDEE mutant would not be 
associated with Asf1 even in the absence of genotoxic stress. However, we found that 
Rad53, and the Rad53-TSSDEE and Rad53-TSSAAA mutants all co-precipitated with Asf1-
myc or with Asf1-T265A+270A-myc in the absence of genotoxic stress (Fig. 15). Thus, 
phosphorylation of Rad53-TSS residues is probably not sufficient to explain dissociation of 
the complex in response to HU treatment. Interestingly however, the Rad53-TSSDEE 
mutant co-precipitated less well with Asf1-myc or Asf1-T265A+270A-myc after treating cells 
with MMS. It is thus possible that phosphorylation of the C-terminal TSS residues of Rad53 
contribute to destabilization of the Asf1-Rad53 complex in response to HU. Phosphorylation 
of other Rad53 sites at the putative third interaction surface of the Asf1-Rad53 complex are 
probably also necessary for destabilization of the complex, and the identification of such 
sites should aid in better defining the third interaction surface. 
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Figure 15. Mutation of possible phosphorylation sites at T811+S812+S821 of Rad53 
destabilizes the Asf1-Rad53 interaction. In absence ou presence of MMS, wild-type Rad53, 
the Rad53-TSSDEE and Rad53-TSSAAA mutant co-precipitate with the Asf1-myc (top) and 
the Asf1T265A+T270A-myc non-phosphorylatable mutant (bottom). 
 
3.2 Deletion analysis of the Rad53 C-terminus  
 
According to the GST-pull down results, our laboratory identified two important 
binding sites for the Asf1-Rad53 interaction: the FHA1 domain of Rad53 binds 
phosphorylated Asf1 at T265 and T270, and the Rad53 C-terminus binds the N-terminal 
domain of Asf1 (Fig. 1 of our submitted manuscript). Before having determined the 
structure of the Rad53 C-terminal peptide with Asf1N, we initially sought to test the 
importance of the Rad53 C-terminus by carrying out a deletion analysis. The C-terminal 
sequence of Rad53 was truncated at different lengths (from 21aa to 91aa) and fused to a 
TAP tag or to GFP (Fig. 16A). A putative bipartite nuclear localization signal (NLS) is found 
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at 785-807 aa of Rad53 (KRIHSVSLSQSQIDPSKKVKRAK). This corresponds to 14-37 aa 
from the C-terminus of the protein. Indeed, we found that deletion of the last 40 aa of 
Rad53 led to a partial delocalization of the protein in the cytosol (Fig. 16B), whereas wild-
type Rad53 is highly concentrated in the nucleus. In order to compensate for this effect, we 
also constructed a Rad53-CΔ40 mutant that contained an SV40 NLS (PKKKRKVG) at the 
junction of the Rad53 truncation with the GFP or the TAP tag. The SV40 NLS restored the 
nuclear localization of the Rad53-CΔ40 mutant (Fig. 16B). Interestingly, we found that the 
Rad53-CΔ40 mutant is sensitive to hyrdoxyurea (HU), but not methyl-methane-sulfonate 
(MMS) or camptothecin (CPT) (Fig. 16C). The addition of an SV40-NLS suppressed the HU 
sensitivity of Rad53-CΔ40 (Fig. 16C). These results suggest that resistance to HU requires 
a higher intranuclear concentration of Rad53 than does resistance to MMS or CPT. 
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Figure 16. (A) Schematic representation of four different mutants of Rad53 that were 
truncated from 21 to 91aa at C-terminus of Rad53. (B) rad53-CΔ40 has a partial 
localization defect. Addition of an SV40 nuclear localization signal can target Rad53 to the 
nucleus. (C) rad53-CΔ40 is mildly sensitive to HU but not to MMS nor CPT, the sensitivity 
to HU is suppressed by addition of an SV40 NLS. (D) asf1-T265A+270A rad53-CΔ40NLS 
rad9 rad24 (28B/28D Td40NLSr9 r24) is more sensitive to HU than rad9 rad24 (33A/36B 
TR53+ r9 r24). asf1-T265A+270A rad53-CΔ40NLS became more sensitive to genotoxic 
stress when it was combined with rad9 or rad24 mutant. T= asf1-T265A+270A allele; 
d40NLS= rad53C∆40-NLS allele; r9= rad9 allele; r24= rad24 allele. The number-letter 
designation refers to tetrad numbers and spore segregants from the genetic cross used to 
isolate the different mutants (i.e, 28B= spore B of tetrad 28). 
 
We next tested the ability of Asf1-myc to co-precipitate with TAP-tagged Rad53 C-
terminal truncation mutants (Fig. 17). All of the Rad53 C-terminal truncation mutants 
precipitated Asf1-myc less well compared to wild-type Rad53, but there was nevertheless 
detectable residual interaction for all mutants. Since the loss of the Rad53 NLS in these 
mutants leads to a partial localization defect, we also tested the ability of the Rad53-CΔ40-
NLS mutant to precipitate Asf1-myc. This mutant also precipitated less Asf1-myc than wild-
type Rad53 despite being properly concentrated in the nucleus. We conclude that loss of 
Rad53-C-terminal sequences destabilized the Asf1-Rad53 complex, but that residual 
interaction was detectable due to distinct interaction surfaces. Since we knew that Rad53-
FHA1 could bind Asf1 phosphorylated on T270 (see submitted manuscript), we tested the 
ability of the Rad53 C-terminal truncation mutants to precipitate the Asf1-T265A+T270A 
mutant. Remarkably, the residual interaction of the Rad53 C-terminal truncation mutants 
with Asf1-T265A+T270A was very similar to that of wild-type Asf1. Furthermore, Rad53-
CΔ40 efficiently precipitated the Asf1-N-terminal domain (1-168 aa) when it was 
overexpressed in yeast (Fig. 17D). We were thus forced to conclude that a third binding 
site must contribute to the interaction of Rad53 with Asf1. As we show in our submitted 
manuscript, this third site appears to involve the histone H3 binding surface of Asf1N with 
an as yet unidentified surface of Rad53 that may lie in its kinase domain (see below).  
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Figure 17. Asf1-myc co-precipitated with TAP-tagged Rad53 C-terminal truncation mutants. 
Asf1-myc (A) and Asf1-T265/270A-myc (B) co-precipitated with Rad53, the Rad53-CΔ40-
NLS-TAP and Rad53-CΔ21-TAP mutant in the absence/presence of MMS. (C) Asf1-myc 
and Asf1-T265+T270A-myc co-precipitated the Rad53-CΔ40-TAP, Rad53-CΔ63-TAP and 
Rad53-CΔ91-TAP mutants. Note however, a problem with the Rad53-C∆91-TAP 
precipitation in the context of the Asf1-T265A+270A mutant strain. (D) The overexpressed 
Asf1-N-terminal domain (1-168 aa) co-precipitated with the Rad53-C∆21-TAP and Rad53-
CΔ40-TAP mutants. 
 
Once Françoise Ochsenbein’s group had determined the structure of the Rad53 C-
terminal peptide with Asf1N, we were able to predict specific residues that were likely to be 
important in affinity of this interaction. As we describe in our manuscript, the Rad53-ALRR 
(A806R+L808R) mutant disrupts an important hydrophobic surface contributing to this 
interaction. In the co-immunoprecipitation experiment shown in this paper, we saw no 
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residual interaction between Rad53-ALRR and Asf1-myc. This seems surprising given that 
we did see a residual interaction between Asf1-myc and Rad53 truncation mutants that 
were completely missing these C-terminal sequences. These experiments were done at 
different times under different conditions. The Rad53 C-terminal truncations were fused to 
the TAP tag and precipitated with IgG beads to test co-precipitation of Asf1-myc. In 
contrast, Asf1-my was precipitated with anti-myc beads to test co-precipitation of Rad53-
ALRR and wild-type Rad53 that were not tagged. The TAP Tag sequence does not contain 
a sequence similar to the KRAXL motif that mediates binding of the Rad53 C-terminus to 
Asf1N, so we do not think that a fortuitous binding motif in the TAP tag explains the residual 
interaction. We suggest that the TAP tag precipitations were done under slightly less 
stringent conditions compared to the Asf1-myc IP, and this allowed us to detect the residual 
interaction of the Rad53-C-terminal truncations. We feel that the Rad53-ALRR mutant also 
has a residual interaction with Asf1 due to the putative third interaction surface, but we did 
not detect this residual interaction under the conditions of the Asf1-myc IP. 
In our manuscript, we showed that the Rad53-ALRR mutant increased the resistance 
of rad9 and rad24 mutants to genotoxic stress. Surprisingly, we found that the Rad53-
CΔ40NLS decreased the resistance of rad9 rad24 double mutants to HU, but not MMS or 
CPT (Fig. 16D). The Rad53-ALRR mutant and the Rad53-CΔ40NLS-TAP mutant are 
expected to destabilize the Asf1-Rad53 complex to similar extents. Since the ALRR double 
point mutant is much more specific than the deletion of the C-terminal 40 aa + fusion of an 
SV40 NLS + TAP tag, we suggest that the differing phenotype of the Rad53-CΔ40NLS-TAP 
mutant is due to an effect on another Rad53 partner or substrate. Although we suggest that 
the phenotype of the Rad53-ALRR mutation is due to destabilization of the Asf1-Rad53 
complex, we cannot exclude that this double point mutation also affects some other partner 
or substrate of Rad53. 
 
 
3.3 Pulldown experiment suggesting that the Rad53 kinase domain can bind Asf1 in 
yeast extracts. 
 
We suggested that Asf1 may directly interact with Rad53 through a third binding site 
overlapping the histone H3 binding surface of Asf1N. We also showed that the Rad53-
K227A and Rad53-K227A+D339A kinase dead mutants were affected in their interaction 
with Asf1 (see submitted manuscript Supplementary Fig. 6A). These observations suggest 
that the Rad53 kinase domain might be able to interact with Asf1, although we did not 
observe an obvious interaction of the Rad53 kinase domain with GST-Asf1 or GST-Asf1N 
purified from E. coli (see submitted manuscript Fig.1B). 
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We re-examined this possibility by testing the ability of a GST-Rad53 kinase domain 
fusion protein produced in E. coli to pull down Asf1 in yeast extracts. Since the GST-Rad53 
kinase domain appears to undergo autophophosphorylation when expressed in E. coli, we 
also treated cell extracts with lambda protein phosphatase before purifying the fusion 
protein. The autophosphorylated and the dephosphorylated GST-Rad53 kinase domain 
fusion protein were both able to pull down Asf1 (Fig. 18A). As expected, GST-FHA1 and 
GST-Rad53-Cter peptides also pulled down Asf1 whereas GST-FHA2 and GST did not. 
These results suggest that the Rad53 kinase domain can interact with Asf1, although it is 
not clear why GST-Asf1 or GST-Asf1N purified from E. coli did not bind the Rad53-His6 
kinase domain expressed in E. coli. Further work is necessary to definitively identify the 
third interaction surface and to provide a complete description of the Asf1-Rad53 complex. 
 
3.4 Glycerol gradient analysis of Asf1 and Rad53 complexes in yeast extracts 
 
We used glycerol gradient centrifugation of total yeast extracts to further characterize 
complexes containing Asf1 and Rad53 in the wild type and in the rad53-ALRR mutant. 
Rad53 was detected with anti-Rad53 antbodies, whereas Asf1 was tagged with HA or myc 
epitopes. Asf1 sedimented in fractions containing Rad53, and in higher molecular weight 
fractions without Rad53, in glycerol gradients prepared from wild-type extracts (Fig. 18B 
top). We also observed some apparently free Rad53 (theoretical MW of 95kDa) in the 
fraction 5, but no free Asf1-HA (50 kDa). In addition to the Asf1-Rad53 complex in fractions 
6-7, Asf1 sediments in higher molecular weight fractions that may represent complexes 
containing histone co-chaperones. Strikingly, in extracts from the rad53-ALRR mutant, Asf1 
sedimented mainly in low molecular-weight fractions that did not contain Rad53-ALRR (Fig 
18B bottom). This observation is consistent with a destabilization of the Asf1-Rad53 
complex in the rad53-ALRR mutant. Curiously, the Rad53-ALRR protein itself sediments 
mainly in fractions 6-7 that correspond to the position of the Asf1-Rad53 complex in wild-
type extracts. This result may indicate that the Rad53-ALRR mutant binds another protein 
of the same approximate molecular weight of tagged Asf1, or that the conformation of the 
Rad53-ALRR protein is more compact than wild-type Rad53 and sediments more rapidly 
for this reason.  
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Figure 18. (A) Rad53 interacts with Asf1 through probably three binding sites. GST pull-
down assays with GST, GST-Rad53FHA1, GST-Rad53 Kinase domain, dephosphorylated 
GST-Rad53 Kinase domain with CIP, GST-Rad53FHA2, GST-Rad53 C-terminal domain 
and yeast extract expressing Asf1-myc. (B) Rad53-ALRR sediments mainly at lower 
molecular weight fractions compared to wild-type Rad53 during glycerol gradient 
centrifugation of yeast extract.  S100 extracts of RAD53 ASF1-3HA (top panel) and rad53-
ALRR/pRS314-ASF1-myc were fractionated on 10-40% glycerol gradients. 
 
Mechanism of the increased resistance of rad9 and rad24 mutants to genotoxic 
stress by the rad53-ALRR mutant 
 
3.5 Overexpression of Rad53 or Asf1 
 
The structure of the complex consisting of Asf1N with the Rad53 C-terminal peptide 
allowed us to identify two residues (A806 and L808) that are important for the stability of the 
complex. The Rad53-ALRR mutant destabilizes the Asf1-Rad53 complex in yeast cells and 
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increases the resistance to genotoxic stress of rad9 and rad24 mutants. It’s possible that an 
increase of free Asf1 or Rad53 is responsible for this increased resistance. We tried testing 
this possibility by transforming a rad9∆ mutant with centromeric or 2µ multi-copy plasmids 
containing the ASF1 or RAD53 genes and testing their resistance to MMS. We did not 
observe a reproducible increase in the resistance of the rad9∆ transformants with these 
plasmids (data not shown). This result suggests that we cannot reproduce the effect of the 
rad53-ALRR mutation by the simple over-expression of wild-type ASF1 or RAD53. 
 
3.6 Phenotype of the asf1-T265+270A mutant  
 
We showed in our submitted m/s that the non-phosphorylatable Asf1-T265+270A 
mutant is unable to bind the Rad53-FHA1 domain. This mutant had no apparent phenotype 
by itself (Fig. 19A) or when combined with the rad53-ALRR (Fig. 19B) or rad24 mutants 
(Fig. 19A). Strikingly however, the asf1-T265+270A rad53-ALRR rad24 triple mutant was 
less resistant to MMS than the rad53-ALRR rad24 double mutant (Fig. 19B). Interpreting 
these results is not simple! The rad53-ALRR mutation clearly destabilizes the Asf1-Rad53 
complex and increases the resistance of the rad24 mutant to MMS. The asf1-T265+270A 
mutation prevents binding of Asf1 to the FHA1 domain of Rad53, but had no effect on the 
efficiency of co-immunoprecipitation of the two proteins from yeast extracts, presumably 
because this interaction contributes little to the overall affinity of the complex compared to 
the two other interaction surfaces of the complex. Thus, we suggest that this phenotype of 
the asf1-T265+270A mutant is explained not by further destabilizing the Asf1-Rad53 
complex, but rather by increasing the interaction of Rad53 with another binding partner of 
its FHA1 domain. Rad53 binds multiple proteins through its FHA1 domain and it is possible 
that in the absence of competition with phospho-Asf1, the increased binding of some other 
protein might lead to increased MMS sensitivity in the context of the rad53-ALRR rad24 
double mutant. This hypothesis is pure speculation that requires further experimental 
testing. 
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Figure 19. Effect of the asf1-T265+270A mutant on HU and MMS sensitivities. (A) asf1-
T265+270A and asf1-T265+270A rad24Δ are not sensitive to genotoxic stress. (B) asf1-
T265+270A rad53-ALRR rad24 exhibit less resistant to MMS than the rad53-ALRR rad24 
mutant. 
 
3.7 Recovery of the rad53-ALRR mutant 
 
The Rad53-ALRR mutation increased the resistance of rad9 and rad24 mutants to 
MMS (see submitted manuscript Fig. 4). Since Rad53 and Asf1 have both been implicated 
in S phase progression, we tested the effect of the rad53-ALRR mutation on cell cycle 
progression after synchronizing cells in the G1 phase of the cell cycle in the absence or 
presence of MMS. Cells were blocked in the G1 phase by treatment with the alpha mating 
pheromone. Cells were then either released into the cell cycle, or treated with 0.005% MMS 
for 30 minutes before washing and releasing into the cell cycle. Recovery from G1 arrest 
and progression through the cell cycle were followed by FACS analysis of DNA content in 
individual cells. Interestingly, exponentially growing rad53-ALRR mutant cells have a higher 
proportion of cells in the S/G2/M phases than the W303-1a wild-type cells (Fig. 20A). The 
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doubling time of the rad53-ALRR mutant is not longer than that of the WT (data not shown). 
This result suggests that the rad53-ALRR mutant has an accelerated G1 phase relative to 
the wild type. After G1 synchronization and release, we found that the rad53-ALRR mutant 
recovered and traversed S-phase more rapidly than the W303-1a wild type in 3 of 5 
experiments. After G1 synchronization, transient MMS treatment, and release, we found 
that the rad53-ALRR mutant recovered and traversed S-phase more rapidly than the W303-
1a wild type in 4 of 5 experiments (Fig. 20B). Overall, these results suggested that the 
rad53-ALRR mutant could re-enter the cell cycle and/or traverse S-phase more rapidly than 
the W303-1a wild type, but this result was not always reproducible and we have so far been 
unable to identify the experimental parameter responsible for this variation. 
 
Figure 20. The rad53-ALRR mutant re-enters the S-phase more rapidly than W303 in the 
absence (A), presence (B), of MMS. Shown is the cell cycle distribution of the wild type and 
the rad53-ALRR mutation measured by flow cytometry analysis of DNA content. Cells were 
synchronized at G1 phase and then released directly into YPD (A) or treated transiently 
with 0.005% MMS and then released into YPD (B).  
 
3.8 Late origin firing is repressed correctly in the rad53-ALRR mutant in the 
continued presence of HU or MMS  
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In the presence of genotoxic stress, the activation of Rad53 inhibits late origin firing 
by phosphorylation of the replisome component Sld3, and by phosphorylation of Dbf4, the 
regulatory subunit of the Cdc7 kinase (Zegerman et al. 2010; Lopez-Mosqueda et al. 2010). 
Kinase-dead mutants of Rad53 do not repress late origin firing and thereby complete DNA 
replication more rapidly than the WT in the continued presence of HU or MMS. We 
synchronized cells in G1 and then released them into medium containing 200 mM HU or 
0.033% MMS to determine whether the rad53-ALRR mutant is able to complete S phase 
more rapidly than the wild type, as would be expected if rad53-ALRR could not repress late 
origin firing. However, the rad53-ALRR mutant had only a modest effect on S phase 
progression in the continued presence of HU or MMS (Fig. 21A).  The rad53-K227A kinase-
defective mutant clearly replicated its DNA more rapidly than the rad53-ALRR mutant in the 
continued presence of MMS (Fig. 21B). This result suggested that the rad53-ALRR mutant 
was competent in blocking late origin firing in response to genotoxic stress.  
Further confirmation of this result was obtained through a collaboration with Armelle 
Lengronne and Philippe Pasero at the Institut de Génétique Humaine de Montpellier. 
Armelle used quantitative PCR to follow the copy number of an early replicating origin (ARS 
305) and three late replicating origins (ARS 809,911, and 1212) in the wild type and rad53-
ALRR mutant after G1 synchronization and release into 200 mM HU. The rad53-ALRR 
mutant showed significant replication of the early origin, but not the late origins in this assay 
(Fig. 21C). In contrast, Lengronne and Pasero have previously shown that mutants 
defective in repressing late origins, such as the rad53-K227A mutant, show significant 
increases in copy number of late origin sequences by this assay (Crabbé et al., 2010). This 
result confirmed the repression of late origins in the rad53-ALRR mutant under conditions 
of genotoxic stress. It remains possible that rad53-ALRR has more subtle effects on S 
phase progression at the level of replication fork initiation or progression. Armelle 
Lengronne is examining this possibility by doing pulse labeling with DNA combing and 
genome-wide analyses of DNA replication in the rad53-ALRR mutant. 
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Figure 21. The rad53-ALRR mutant is competent at repressing late origin firing in the 
presence of genotoxic stress. (A) the rad53-ALRR mutant had only a modest effect on S 
phase progression in the continued presence of HU or MMS. (B) The rad53-K227A kinase-
defective mutant that is defective in repressing late origins replicated its DNA more rapidly 
than the rad53-ALRR mutant in the continued presence of MMS. (C) the DNA copy number 
of early/late origins of the rad53-ALRR mutant was examined after G1 synchronization and 
release into medium containing HU. The significant replication of the early origin (ARS 305), 
but not the late origins (ARS 809, 911, 1212) was detected. 
 
3.9 Are the effects of rad53-ALRR on cell cycle progression due to the disruption of 
the Asf1-Rad53 interaction?  
 
The rad53-ALRR mutation destabilized the Asf1-Rad53 complex (see submitted 
manuscript Fig. 4B). It is thus possible that the effects of this mutation on cell cycle 
progression are due to increased levels of free Rad53 and/or Asf1 in the mutant. We 
sought to further test this possibility by examining the effects of individual over-expression 
of RAD53 or ASF1 in the wild-type strain. We also tested the effect of other mutations that 
affect the interaction of Asf1 with Rad53, such as the rad53-TSSDEE, rad53-CΔ40NLS or 
rad53CΔ40NLS-asf1T265+270A. 
To determine whether overexpression of Asf1 or Rad53 has an effet on cell cycle 
progression, we transformed the W303-1a wild-type with 2µ multi-copy plasmids containing 
the ASF1 or RAD53 genes. These plasmids were previously shown to lead to an 
accumulation of Asf1 and Rad53. After G1 synchronization and release in the absence of 
MMS treatment, we did not observe an obvious effect of Rad53 or Asf1 overexpression on 
cell cycle progression (Fig. 22A). In this experiment, we do not observe an effect of the 
rad53-ALRR mutation either. As mentioned above, the accelerated recovery from G1-arrest 
and S-phase traversal of the rad53-ALRR mutant was not always reproducible for unknown 
reasons. Interestingly however, the rad53-TSSDEE and rad53CΔ40NLS-asf1T265+270A 
mutants did show accelerated cell cycle progression in this experiment (Fig. 22A).  
We also examined cell cycle progression after G1 arrest, transient treatment with 
0.005% MMS for 30 minutes, and then wash and release into normal growth medium. 
Although Asf1 overexpression did not alter recovery from MMS and subsequent cell cycle 
progression, Rad53 overexpression did accelerate this process in a manner similar to the 
rad53-ALRR mutation (Fig. 22B). The rad53-TSSDEE and rad53CΔ40NLS-asf1T265+270A 
mutants also showed accelerated recovery from MMS and cell cycle progression in this 
experiment. We also included an asf1∆ mutant in this experiment. There is no Asf1 to form 
a complex with Rad53 in this strain. However, unlike the rad53-ALRR mutant, the asf1∆ 
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mutant grows more slowly than the wild type and appears to suffer from endogenous DNA 
damage that leads to basal activation of Rad53 and accumulation of cells in S/G2/M 
(Ramey et al., 2004). The asf1∆ mutant is also hyper-sensitive to MMS. The FACS analysis 
indicated that the asf1∆ mutant also showed accelerated recovery from MMS and cell cycle 
progression (Fig. 22B). However, the G1 arrest induced by alpha factor appeared to be less 
effective, so this experiment should be repeated in optimized synchronization conditions. 
Overall, these results suggest that increases in free Rad53 (not complexed with Asf1) 
in the rad53-ALRR, rad53-TSSDEE, and rad53CΔ40NLS-asf1T265+270A mutants, or by 
RAD53 overexpression in the wild-type strain, can promote more rapid recovery from 
transient MMS treatment and cell cycle progression. However, it is not clear how these 
initial effects on recovery from MMS are related to the long-term survival of these strains to 
MMS. For example, we did not observe obvious differences in the sensitivity of the rad53-
ALRR, rad53-TSSDEE, and rad53CΔ40NLS-asf1T265+270A mutants to MMS relative to 
the wild type. As shown in our paper, the rad53-ALRR mutation does increase the 
resistance of rad9 and rad24 mutants to genotoxic stress, and so we decided to study this 
phenotype more closely. 
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Figure 22. Shown is the cell cycle distribution of different mutations affecting the Asf1-
Rad53 interaction mesured by flow cytometry analysis of DNA content. (A) In the absence 
of MMS, overexpression of Rad53 nor Asf1 has no obvious effect on cell cycle progression, 
whereas the rad53-TSSDEE and rad53-CΔ40NLS asf1-T265A+270A mutants accelerated 
cell cycle progression. (B) In the presence of 0.005% MMS, the asf1∆, overexpression of 
Rad53 or rad53-TSSDEE, rad53CΔ40NLS-asf1T265+270A mutants accelerated recovery 
from MMS.  
 
3.10 Recovery of rad24 versus rad53-ALRR rad24 mutants to MMS treatment. 
 
We would like to understand how the rad53-ALRR mutant increases the resistance of 
the rad24 mutant to MMS treatment. We used a microcolony assay to follow the response 
of individual yeast cells to this treatment. Cells were treated with MMS for 30 minutes, and 
the cells were then diluted to 105-106 cells/ml and spread on the surface of the YPD plate. 
The number of individual cells/micro-colonies was then counted in a microscope after 20 
hours of incubation. We classified cells in five different categories: cells that could form a 
viable microcolony of cells (class MV), cells that formed a microcolony of 16 cells or less 
indicating that the founding cell had undergone four or fewer divisions, but ultimately all 
cells were dead (class MM), individual cells that died without a bud (class 0), and individual 
cells with one, two, or three buds (classes 1, 2 and 3).  
After treatment with 0.005% MMS, most WT and rad53-ALRR mutant cells formed 
viable micocolonies, with the remainder mainly in the form of abortive microcolonies of 
dead cells. In contrast, after treated with 0.05% MMS, most cells formed abortive 
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microcolonies of dead cells (Fig. 23A, B). As expected, the rad53-ALRR rad24 mutant was 
more resistant to MMS compared to the rad24 single mutant. Interestingly, both strains died 
mainly in the form of abortive microcolonies, indicating that cells were not permanently 
blocked in their division cycle after MMS treatment. Instead, cells underwent 3-4 divisions 
on average before dying with damage incurred by MMS. We were surprised that most cells 
could undergo several division cycles with ultimately lethal damage. Since Rad24 is 
implicated in activating one branch of the DNA damage checkpoints, it was possible that 
these divisions were due to defects in checkpoint activation in the rad24 mutant. We thus 
monitored the response of W303-1a wild-type cells, and the apn1∆ apn2∆, rad53-ALRR, 
rad24, and rad24 rad53-ALRR mutant cells to treatment with 0.005% MMS (Fig. 23C). The 
apn1∆ apn2∆ mutant is defective for the two APN endonuclease activities in yeast, but has 
a functional DNA damage checkpoint response. This mutant can excise methylated DNA 
bases, but is defective in cleaving the DNA strand at the abasic sites and repairing the 
damage. This repair defect makes the mutant hypersensitive to MMS. Interestingly, the 
apn1∆ apn2∆ mutant cells also died almost exclusively in the form of abortive microcolonies. 
This result contrasts with the response of budding yeast cells to persistent DNA double-
strand breaks in which most cells are blocked before nuclear division by the DNA damage 
checkpoints. We conclude that the lethal damage incurred by yeast cells after MMS 
treatment is probably not due to DNA double-strand breaks, but rather some other form of 
damage that is compatible with limited proliferation before cell death. The results suggest 
that the increased viability after MMS treatment of rad53-ALRR rad24 compared to the 
rad24 may be due to increased repair or tolerance, rather than a difference in recovery from 
cell cycle arrest. 
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Figure 23. Microcolony viability analysis in rad24 versus rad53-ALRR rad24 strains. Cells 
were treated with 0.005% (A) or 0.05% (B) MMS for 30 minutes, then were released on 
YPD plates. The number of viable microcolonies (mv), dead microcolonies (mm) or cells 
with 0,1, 2, 3 buds is expressed as the percentage. (A) most rad24 and rad53-ALRR 
mutant cells formed viable micocolonies and the remainder mainly formed abortive 
microcolonies of dead cells after treatment with 0.005% MMS. (B) most cells formed 
abortive microcolonies of dead cells after treated with 0.05% MMS. (C) most apn1∆ apn2∆ 
cells treated with 0.005% MMS also died in the form of abortive microcolonies. 
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3.11 Adaptation of rad24 versus rad53-ALRR rad24 mutants to continuous MMS 
treatment. 
 
We showed in our submitted m/s that the rad53-ALRR rad24 mutant grows better in 
the continued presence of 0.0025% MMS than does the rad24 single mutant. We used the 
microcolony assay to examine the behaviour of individual cells in the continued presence of 
0.05% MMS to characterize their cell cycle arrest under these conditions. W303, rad53-
ALRR, rad24 and rad53-ALRR-rad24 cells were synchronized in the G1 phase by alpha 
factor treatment and cells were spread onto YPD plate containing 0.05% MMS. Individual 
cells were visualized in a microscope after incubating for 1h30 or 16h (Fig. 24 A,B). We 
counted the number of buds or individual cell bodies, since cells did not form microcolonies 
under these conditions of continuous exposure to 0.05% MMS (Fig. 25). The rad53-ALRR 
mutant budded more rapidly than all other strains after 1h30 of incubation in MMS (Fig. 
24A), whereas the rad24 single mutant remained mainly unbudded and the W303-1a wild-
type and rad53-ALRR rad24 double mutant showed intermediate behaviour. After overnight 
incubation in the presence of MMS, all strains were mainly blocked as single cells with one 
large bud. There were no major differences in the behaviour of W303-1a wild type, the 
rad24 single mutant, and rad24 rad53-ALRR double mutant strains. However, the rad53-
ALRR single mutant did form significantly higher numbers of cells containing three or more 
cell bodies (Fig. 24B). Altogether, these results suggest that the rad53-ALRR mutant shows 
higher levels of resistance and/or adaptation to the cell cycle arrest provoked by the 
continuous exposure of cells to 0.05% MMS compared to the wild type. It is possible that 
this resistance/adaptation contributes to the better growth of rad53-ALRR rad24 double 
mutants compared to rad24 single mutants on plates containing a lower level of MMS 
(0.0025%). 
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Figure 24. Microcolony analysis of adaptation to MMS-induced cell-cycle arrest in wild 
type, rad53-ALRR, rad24 and rad53-ALRR rad24 strains. Cells were spread on YPD 
plates containing 0.05% MMS for 1h30 (A) or overnight (ON) (B). The number of cells with 
0,1, 2, 3, or more than 3 buds is expressed as the percentage of total cells. The rad53-
ALRR mutant showed a better resistance and/or adaptation to the cell cycle arrest.  
 
 
 
Figure 25. Individual cells were visualized in a microscope after ON treatment with 0.05% 
MMS. (A) rad53-ALRR cells dying with buds. (B) wild-type cells dying with only one or two 
buds. 
 
 
A 
A B 
B 
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3.12 Rad52-YFP foci in rad53-ALRR versus the wild type 
 
Rad52 stimulates strand exchange by facilitating a recA-like protein Rad51 binding to 
single-stranded DNA. It is recruited to resected DNA double-strand breaks where it 
participates in repair by homologous recombination pathways. The presence of such DSBs 
in yeast cells can be visualized as intranuclear foci of Rad52-YFP. The quantification of the 
percentage of yeast cells with Rad52-YFP foci has been used to evaluate the efficiency 
with which mutant cells can repair DSBs. Wild type and rad53-ALRR cells expressing 
Rad52-YFP were treated with 0.01% MMS for 1h45, washed with PBS, and Rad52-YFP 
foci were then observed by fluorescence microscopy (Fig. 26). The percentage of wild type 
cells containing Rad52-YFP foci (26.7%) was similar to that of rad53-ALRR cells (23.2%) 
under these conditions. These observations suggest that there is no obvious difference in 
the generation or repair of MMS-induced DSBs in the rad53-ALRR mutant compared to the 
wild type. 
 
 
 
Figure 26. Example of a yeast cell expressing  
a focus of Rad52-YFP observed by fluorescence  
microscopy. 
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Materials and Methods 
 
Co-immunoprecipitation 
 
Cells were harvested at an O.D. 600nm of 0.8 and resuspended in 4 ml extraction buffer 
(50mM Tris pH 7.5, 100 mM NaCl, 10% glycerol, Roche protease inhibitor cocktail w/o 
EDTA) and broken in an Eaton press. Extracts were transferred to 50 Ti tubes and 
centrifuged (40 krpm, 1h, 4°C), and the protein concentration in the supernatant was 
determined with the Bradford reagent (Bio-Rad). Extracts (5 to 10 mg of protein for anti-myc 
IP in a final volume of 1 ml) were incubated with anti-myc beads/anti-IgG agarose that had 
been washed with extraction buffer on a rotating wheel O/N at 4°C. The beads were 
washed two times with 1 ml extraction buffer + 0.1% Tween-20 and immunoprecipitated 
proteins were solubilized by heating in the presence of sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. Total cell extracts (40 µg) 
and immunoprecipitated proteins were seperated by SDS-PAGE, transferred to 
nitrocellulose membranes, incubated with primary antibodies followed by secondary 
antibodies. Proteins were detected using a Li-Cor Odyssey Imager. 
 
GST-pull down Assay 
 
40 µg purified (His)6-GST-fusion proteins were immobilized on reduced glutathione agarose 
beads and equilibrated with 20 mM Hepes. 1mg yeast extract containing Asf1-myc was 
incubated with 50 µl beads for 30 min at 4°C. The beads were collected by centrifugation, 
washed twice in 20 mM Hepes and two times in 20 mM Hepes, 50 mM NaCl, 0.5% NP40. 
Bound Asf1 was analyzed by SDS-PAGE and revealed by 9E10 (anti-myc) antibody. 
(His)6-GST fusion proteins were revealed by anti-GST antibody. 
 
Glycerol gradient centrifugation of yeast cell extracts 
 
10-40% (v/v) glycerol gradients in 20 mM Hepes (pH 7.5) + 100 mM NaCl were poured in 
SW56 centrifuge tubes. Cells were broken in an Eaton press and 10 mgs of an S100 
extract of W303-1a or CMY1562 cells were added to the top of the gradients and the tubes 
were spun at 45 krpm (200,000 x g) for 18h at 4°C. Proteins in 330 µl fractions were then 
precipitated by adding TCA to 25% final concentration and incubating on ice for 15 min 
followed by centrifugation at 22,000 x g for 20 min at 4°C. Pellets were washed with 0.5 ml 
cold acetone, air dried, and resuspended in SDS-PAGE sample buffer. Glycerol gradients 
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were calibrated using a mixture of BSA (67 kDa), lactate dehydrogenase (140 kDa), 
catalase (232 kDa), and ferritin (440 kDa). 
 
Phenotypic analysis 
 
For spotting analyses, cells were resuspended at 107/ml, subjected to 10-fold serial 
dilutions and 3µl of each dilution was spotted on plates of YPD, YPD + 100 mM HU, and 
YPD + 0.0025% MMS. Growth was assayed at 72h.  
 
Cell synchrony and flow cytometric analysis (FACS) 
 
Yeast cells were arrested with α-factor (30 µM). Cells were then either released into YPD, 
or treated with 0.005% MMS for 30 min, washed and released into YPD, or treated with 
0.033% MMS or 200 mM HU. Cells were harvested every 15 min and fixed in 70% ethanol 
at 4°C for a minimum of 15 min. Fixed cells were washed in PBS and incubated with 0.25 
mg/ml RNase A in PBS for 1h at 50°C. Afterwards, propidium iodide was added to a final 
concentration of 50 µg/ml and cells were incubated at RT in the dark for 15 min. DNA 
content was analysed by FACSCalibur (Bekton-Dickinson) and the Cell Quest software 
(Becton-Dickinson). 
 
Viability test (recovery/adaptation) 
 
Recovery: Cells were synchronized or not in G1 with 30 µM α-factor, then treated with 0.05% 
MMS or 100 mM HU for 1h30. After washing with YPD, cells were diluted to 105-106 cells/ml 
and 5µl of cells were spread on the surface of the a YPD plate. The number of individual 
cells/micro-colonies was then counted in a microscope after 20h of incubation at 30°C. 
Adaptation: Cells were synchronized in G1 with α-factor and washed with YPD, then cells 
were diluted to 105-106 cells/ml and 2µl of cells were spread on the surface of the a YPD 
plate containing 0.05% MMS. The number of individual cells was then counted in a 
microscope after 1h30 and O/N incubation at 30°C. 
 
Rad52-YPF foci 
 
Cells were treated with 0.01% MMS for 1h45 and washed with PBS. The Rad52-YFP foci 
were then observed by fluorescent microscopy. 
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Yeast strains.  
All strains were in the W303 background, except for CMY1384, CMY1389 and CMY1520 in 
the S288C background and CMY1357 and 1360 in the YPH250 background. 
 
W303-1a  MATa ade2-1 his3-11,15 leu2-3, 112 trp1-1 ura3-1 
CMY1139 W303-1a rad53::HIS3  sml1-1 
CMY1155  W303-1a rad24::URA3 
CMY1156  W303-1a rad9::HIS3 rad24::URA3 
CMY1158 W303-1a rad9::HIS3 
CMY1227  W303-1a rad53::HIS3/pBAD70 (2µ,TRP1)-RNR1  
CMY1392 W303-1a RAD5+ RAD52-YFP bar1::LEU2 
CMY1396 W303-1a ASF1-3HA-kanMX6 bar1::LEU2 his3-11 leu2-3,112 lys2 trp1-1 
ura3-1 
CMY1411 W303-1a rad53CΔ40-TAPtag::HIS3MX 
CMY1412 W303-1a rad53CΔ63-TAPtag::HIS3MX 
CMY1413 W303-1a rad53CΔ91-TAPtag::HIS3MX 
CMY1426 W303-1a rad53CΔ21-TAPtag::HIS3MX 
CMY1453 W303-1a rad53CΔ40-NLS-TAPtag::HIS3MX 
CMY1501 SEY1127 W303-1a mrc1∆-3::his5+  
CMY1558   W303-1a rad53-TSSDEE::URA3::rad53∆::HIS3 
CMY1561 W303-1a rad53-K227A::kanMX 
CMY1562   W303-1a rad53-ALRR::URA3::rad53∆::HIS3 
CMY1563 W303-1a RAD53::URA3::rad53∆::HIS3 
CMY1564   W303-1b rad53-ALRR::URA3::rad53∆::HIS3 
CMY1565 W303-1 rad53-ALRR::URA3::rad53∆::HIS3 mrc1∆-3::his5+ 
CMY1566   W303-1a rad53-ALRR::URA3::rad53∆::HIS3 rad24::kanMX 
CMY1567   W303-1a rad53-ALRR::URA3::rad53∆::HIS3 rad9::LEU2 
CMY1568   W303-1a rad53-ALRR::URA3::rad53∆::HIS3 rad24::kanMX rad9::LEU2 
CMY1569   W303-1a rad9::LEU2 
CMY1570   W303-1a rad24::kanMX  
CMY1571  W303-1a rad24::kanMX rad9::LEU2 
CMY1364  W303-1b asf1∆::kanMX 
CMY1384 EY0986 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 RAD53-TAP::HIS3MX6 
(Ghaemmaghami et al, 2003) 
CMY1389  FY2162 MATa his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128∂ Ty912.35-
lacZ::his4 (hht1-hhf1)Δ::LEU2 (hht2-hhf2)Δ::HIS3/pDM9=pRS416(CEN URA3)-
HHT1+HHF1    
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CMY1520  MATa his3Δ200 leu2Δ1 ura3-52  trp1Δ63  lys2-128∂  Ty912.35-lacZ::his4  
(hht1-hhf1)Δ::LEU2  (hht2-hhf2)Δ::HIS3/ pDM18 (CEN TRP1)-hht2-R129E+HHF2 
CMY1357  YDH6 ade2–101 his3-200 leu2-1 lys2–801 trp1-1 ura3–52 cka1-1::HIS3 
cka2-1::TRP1/ pCEN6-LEU2-CKA2  
CMY1360 YDH13 ade2–101 his3-200 leu2-1 lys2–801 trp1-1 ura3–52 cka1-1::HIS3 
cka2-1::TRP1/ pCEN6-LEU2-cka2-13ts  
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Conclusions and perspectives 
 
Our results suggest that the Asf1-Rad53 interaction appears to involve three distinct 
interaction surfaces. The Rad53-FHA domain binds Asf1 phosphorylated at T270 in 
its C-terminal acidic tail domain in a casein kinase II-dependant manner. The C-
terminal 21 aa of Rad53 binds the same surface of the conserved Asf1 N-terminal 
domain where the histone co-chaperones HirA/CAF-1 and histone H4. There should 
be a competition amongst these three proteins to bind the same surface of Asf1. 
These results explain why they form exclusive complexes with Asf1. The putative 
third interaction site may involve the histone H3 binding surface of Asf1 with an 
unknown surface of Rad53 that may reside in its kinase domain. We could further test 
this third interaction surface by two-hybrid analyses, but structural work will be also 
required to test this model. We encountered unexpected difficulties in reconstituting a 
complex of Rad53 and the N-terminal domain of Asf1 from purified recombinant 
proteins. We suspect the problem to lie in the conformation of the unphosphorylated, 
inactive Rad53 that seemed incompetent for binding Asf1N in vitro and was readily 
lost by non-specific sticking to surfaces. We suggest that the proteins must be co-
expressed, and/or require specific chaperones, to form a productive complex. We co-
expressed the kinase-defective Rad53-K227A (to prevent autophosphorylation) and 
Asf1N in E. coli, but still failed in obtaining a complex of the two proteins. We should 
perhaps test co-expression of wild-type Rad53 with Asf1N. Perhaps Asf1N can bind 
Rad53 and prevent its autophosphorylation in E. coli. However, it is also possible that 
E. coli does not express appropriate chaperones for this complex. Another possibility 
would be to test co-expression from baculovirus. The complex can of course be 
purified from S. cerevisiae, but the yield will not be high unless the complex can be 
over-expressed. The X-ray structure will no doubt be necessary to give us a complete 
picture of the unexpected intricacies of this complex. 
Rad53 and Asf1 form a complex in yeast cells in the absence of genotoxic stress. We 
found that the Asf1-Rad53 complex was dissociated when cells were treated with 
hydroxyurea, a ribonucleotide reductase inhibitor, but not when cells were treated 
with the methylating agent MMS. The phosphorylation sites of Rad53 are likely to be 
different in response to HU and MMS. Phosphorylation sites at the putative third 
interaction surface of the Asf1-Rad53 complex are probably required for dissociation 
of the complex in presence of HU. Rad53 phosphorylation sites have been mapped 
after treating cells with MMS, but not HU. Thus, it will be important in the future to 
search for phosphorylation sites on Rad53 after treating cells with HU. This could be 
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done by mass spectrometry analyses on TAP-tagged Rad53 purified from HU-treated 
cells. Identifying phosphorylation sites specific to HU will allow their mutation to test 
their importance in dissociation of the complex in response to HU and in the general 
cellular response to HU. They would also pinpoint the surface of Rad53 that is 
involved in the third interaction surface of the Asf1-Rad53 complex. 
 
From the structure of Asf1N and the Rad53 C-terminal peptide, we were able to 
identify the residues A806 and L808 of Rad53 as being important for the affinity of the 
complex. We found that the rad53-ALRR mutation destabilized the Asf1-Rad53 
complex in yeast cells. Although this mutant did not have an obvious phenotype on its 
own, we found that it increased the resistance to HU and MMS of rad9 and rad24 
mutants. Rad9 and Rad24 are implicated in recruitment and activation of Rad53 at 
DSBs. The rad53-ALRR mutation did not significantly modify the profile of Rad53 
phosphorylation, so the increased viability of rad53-ALRR rad9 rad24 mutants 
exposed to HU or MMS may not be through effects on Rad53 activity. Though the 
FACS results of the rad53-ALRR mutant were not always reproducible, we observed 
that the rad53-ALRR mutant could re-enter the cell cycle and/or traverse S-phase 
more rapidly than wild type. The correct repression of late origin firing of this mutant in 
response to genotoxic stress was confirmed by a collaboration with Armelle 
Lengronne and Philippe Pasero. They are also examining whether the rad53-ALRR 
mutant has an effect on S phase progression at the level of replication fork initiation 
or progression by DNA combing and BrdU genome-wide incorporation experiments. 
Interestingly, Armelle has told us that some rad53-ALRR phenotypes resemble those 
of mutants with increased dNTP pools, such as sml1∆ mutants. It will thus be 
interesting to test dNTP levels in the rad53-ALRR mutant. Hopefully, the genome-
wide experiments will give us a definitive response of the effect of the mutant on DNA 
replication and further clues for future experimentation.   
The increased viability of Rad53-ALRR rad24 double mutant compared to rad24 may 
due to an increased repair or adaptation. Further work on testing the effect of the 
mutant on DNA repair after treatment with MMS could potentially be done by pulsed-
field gel electrophoresis (PFGE) or by DNA comet analysis. Using G1 synchronized 
cells for MMS treatment would also allow us to follow Rad53 activity by the Rad9-
Rad24 pathway without the contribution of the Mrc1 pathway and may allow us to see 
effects of the rad53-ALRR mutation on adaptation/recovery at the level of the Rad53-
ALRR mutant kinase.  
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